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ABSTRACT 
This paper reviews the prognosis of left main coronary artery (LMCA) 
obstruction and evaluates experience to date of medical and surgical therapy. 
Physiologic principles of intra-aortic balloon counterpulsation are dis¬ 
cussed., and applications and complications of clinical usage reviewed. We 
report on the operative results of 91 consecutive patients with greater than 
or equal to 50% stenosis of the LMCA undergoing bypass surgery at Yale-New 
Haven Hospital from July 1975 through December 1977. Incidence of operative 
death and perioperative myocardial infarction is analyzed for subgroups of 
patients assisted and unassisted with counterpulsation prior to surgery. The 
preoperative risk profile of 36 patients receiving the intra-aortic balloon 
pump (IABP) is compared with that of 56 patients not receiving the pump to 
evaluate possible grouping biasing. Of 26 demographic, clinical, hemodyn¬ 
amic and operative descriptors, the only parameters found to differ signifi¬ 
cantly between the groups were the severity and pattern of anginal symptoms 
prior to admission. The assisted group had a greater proportion of patients 
with New York Heart Association Class IV angina (80% vs. 45%) and a higher 
percentage with unstable angina (37% vs. 7%) . The assisted group, despite 
presenting poorer presurgical clinical symptoms, had a significantly lower 
incidence of perioperative infarction (23% vs. 3%, p 0.05) and a reduced, 
but not statistically significant, rate of operative death (11% vs. 6%). 
Additive properties for operative risk were established for the presence 
of additional disease of the right coronary artery and not using the IABP, 
as well as for prolonged duration of cardiopulmonary bypass and not assist¬ 
ing with counterpulsation. Vulnerable periods during bypass operations are 
discussed and the possible role of the IABP in ameliorating myocardial 
-i- 

vulnerability during these phases reviewed. It is suggested that the intra¬ 
aortic balloon pump can be of significant benefit when used preoperatively 
for patients with left main stenosis going to bypass surgery. 
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INTRODUCTION 
Coronary artery disease (CAD) is estimated to affect more than 5 
million individuals and annually account for greater than 650,000 deaths, 
or over 37 percent (%) of the total mortality in the United States (1-4). 
The natural history of symptomatic CAD can include angina pectoris of 
varying severity, myocardial infarction (MI), congestive heart failure, 
arrhythmias, and increased risk of death. The overall annual mortality 
of cardiac origin after clinical diagnosis of angina pectoris is currently 
3 to 13% with a 5-year mortality of 15 to 44% (5-13). At particularly 
high risk is the subgroup of patients with significant occlusive disease 
of the left main coronary artery (IMCA) comprising approximately 7 to 10% 
of patients with angina pectoris (8,14-23). The risk of death in the first 
year following diagnosis in this subgroup is 15 to 30%, and in the second 
year an additional 10 to 15% with a 5-year cardiac mortality rate of 50 to 
60% (8,14-26). Early surgical intervention has, thus, become increasingly 
common for this disease, and many centers have reported prolonged survival 
and alleviation of symptoms in surgically treated groups (17,22,25,27-33). 
Obstruction of the left main coronary artery is itself a significant 
risk factor for operative mortality and for the occurrence of myocardial 
infarction during or in the period immediately following bypass (8,17,21, 
22,30,33-35). Operative mortality has been reported to be two to five 
fold higher and perioperative infarction over 50% more common in patients 
with significant left main narrowing. Such experience is of obvious 
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concern to cardiologists and surgeons who must weigh the benefit against 
risk of surgery and make recommendations to patients in this category. . 
The intra-aortic balloon pump (IABP) has been used clinically since 
1968 to support the circulation and alleviate myocardial ischemia in a 
variety of cardiac and noncardiac disorders (36-40). Experience with 
prophylactic intra-aortic balloon counterpulsation for cardiac surgery 
has demonstrated a value for its use in patients with serious left ventri¬ 
cular dysfunction, impending myocardial infarction, or both (41-43). 
Recent reports suggest, in addition, a possible benefit of using the 
IABP prophylactically in patients with left main disease undergoing by¬ 
pass surgery (23,30,44). This study will evaluate preoperative intra¬ 
aortic balloon counterpulsation for patients undergoing aorto-coronary 
bypass grafting for left main obstruction in recent experience at Yale- 
New Haven Hospital. We prospectively collected data on 91 consecutive 
patients having bypass surgery for main left coronary stenosis from July 
1975 through December 1977 to determine if using the IABP had any effect 
on the incidence of operative deaths and perioperative myocardial in¬ 
farction. 
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A REVIEW OF THE LITERATURE AND HISTORICAL BACKGROUND 
The history of left main coronary (LMCA) stenosis began in 1912 when 
James Herrick wrote the first clinical description of acute myocardial in¬ 
farction (45). Herrick described a 55 year old male patient dying in 
cardiogenic shock after a period of 52 hours, who at autopsy was found to 
have total occlusion of the LMCA by a thrombus overlying an area of ather¬ 
osclerotic narrowing. There was associated extensive necrosis of the left 
ventricle. 
The main left coronary artery carries the primary blood supply to 
the free wall and apex of the left ventricle as well as to the interventri¬ 
cular septum (46). Obstructive disease of the short segment proximal to 
the bifurcation of the main stem into the left anterior descending (LAD) 
and left circumflex (LCF) arteries thus endangers all but the inferior 
and posterior surfaces of the ventricle. 
Appreciation of the ominous nature of LMCA stenosis was based pri¬ 
marily on autopsy documentation of obstruction of the LMCA in patients 
dying suddenly until 1972, when Cohen and associates published the first 
clinical and catheterization studies of clinical correlates and prognosis 
of LMCA disease (47). Fifty percent of their patients with LMCA stenosis 
treated nonsurgically died within an average follow-up period of 25 months. 
The mortality of the surgical group was also very high (29%), in addition 
to a high mortality encountered at the catheterization procedure itself 
(16%). While the numbers in this study were small and angiographic and 
surgical technique non-refined, the paper outlined several important areas 
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for subsequent study in this group: determining the incidence of LMCA 
disease among patients with coronary disease, quantitating prognosis, 
recognizing and reducing the risk of coronary angiography, determining 
if specific historical, physical, or laboratory features might distinguish 
1HCA lesions prior to catheterization, and evaluating methods of therapy. 
Incidence of LMCA Disease 
Since 1972 many centers have published the results of their catheter¬ 
ization experience with specific reference to left main lesions, outlining 
angiographic correlates to clinical data and follow-up history. Recognizing 
the heterogeneity of population groups resulting from referral patterns, 
variations in technique, different follow-up periods, and varying methods 
of presentation and analysis, we find it difficult to make direct compari¬ 
sons among the studies and come up with definitive statements regarding 
aspects of left main disease. Strong patterns, however, do emerge and in 
the table below we have listed combined data to provide an overall idea 
of the expected parameters of LMCA lesions. 
Table 1 shows the incidence of stenotic lesions of greater than 
50% of the LMCA as reported by various investigators among patients 
undergoing coronary angiography (8,14-17,19,20,22,26). 
A weighted average has been calculated and standard deviation for 
the populations noted. The range of incidence of LMCA is 2.6% to 11.1% 
in the reports with an average of approximately 7%. 
-4- 

Table 1. Incidence of _> 50% LMCA Narrowing Among Patients Undergoing 
Angiography 
Reference Investigators No. of Patients % of pts. undergoing 
angiography with >501 
LMCA stenosis 
8 Bruschke et al, 
1973 
590 6.3 
14 Cohen and Gorlin, 
1975 
500 8.2 
15 Proudfit et al, 
1967 
1000 5.9 
16 Takaro et al, 
1976 
VA Randomized Study 
1015 11.1 
17 Farinha et al, 
1978 
4196 7.0 
19 Khaja et al, 
1974 
695 4.0 
20 DeMots et al, 
1975 
2450 2.6 • 
22 Oberman et al, 
1976 
3081 5.8 
26 Conley et al, 
1978 
3498 9.0 
17,025 6.6% 
a=2.3 
TOTAL: 
n 

It is difficult to assign a precise interpretation to this figure regarding 
the prevalence of LMCA disease among patients with coronary disease (CAD) 
in general, as these series reported frequency as a function of all patients 
undergoing angiography ^a^portion of whom did not have CAD. The prevalence 
of LMCA disease in the CAD population is thus, probably somewhat higher 
than 7% . In the Cleveland Clinic series, for example, of the 1000 patients 
catheterized, only 588 had angiographic evidence of coronary artery obstruc¬ 
tion (15). Ten percent of these 588 patients had significant left main 
obstruction. 
Prognosis of LMCA Obstruction 
In evaluating the available data concerning the natural history of 
LMCA disease, we chose to study those reports which had no surgical 
patients and those with randomized non-biased groupings in order to 
eliminate any selection factor associated with choosing surgical candi¬ 
dates. These studies are combined in Table 2: (8,14,16,18,20,25-27,32). 
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Table 2. Prognosis After Diagnosis of >50% Obstruction of LMCA 
Reference Investigator No. of Cumulative Mortality Rate (%) 
Pts. 6 mo. 1 yr. 18 mos. 2 yr. JLzl, 4 yr. 5 yr. 
8 Bruschke et al, 
1973 
37 29 40 47 57 57 
14 Cohen and Gorlin, 
1975 
17 44 51 71 
16 Takaro et al, 
1976 
VA Randomized 
Study 
53 20 29 32 32 33 
18 Lavine et al, 
1972 
9 33 
20 DeMots et al, 
1975 
19 10 16 37 47 57 74 
25 Talano et al, 
1975 
51 38 48 48 61 
26 Conley et al, 
1975 
163 15 21 36 50 
27 Lim et al, 
1975 
141 21.9 34.7 43 51 
32 Campeau et al, 
1978 
114 7 21 36 40 50 
Total No. 
Patients 
604 295 578 123 595 544 187 292 
Average: 20.1% 21.9% 39.4% 35.4% 43.7% 49.6% 51.3% 
a: 9.0 10.6 7.4 10.2 6.6 13.0 2.2 
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Inherent in these data is variability among population groups with 
respect to degree of LMCA narrowing, left ventricular dysfunction, in¬ 
volvement of the right coronary artery, and other clinical parameters. 
While this table is an oversimplification of the prognosis following diag¬ 
nosis of LMCA obstruction (vide infra), indeed the risk of death is clearly 
very high. The mean mortality for patients with >50% obstruction of the 
LMCA following diagnosis is 20% at 6 months, 22% at one year, 35% at 2 
years, 44% at 3 years, and 51% at 5 years. 
While the studies listed in Table 2 have excluded from analysis 
known catheterization related deaths, the high mortality in the first 6 
months may bear some relationship to the catheterization procedure itself, 
as many centers in the late 1960's and early 70's reported a high mortality 
among patients with this lesion during and in the first month following 
angiography (17-20,47,48). The early study by Cohen et al (47) of 32 
patients catheterized from January 1964 to May 1971 with LMCA stenosis 
reported 5 catheterization-related deaths (16%), 3 of whom had cardiac 
arrest immediately after introduction of the catheter into the left coro¬ 
nary ostium and 2 suffering myocardial infarction during the procedure 
and succumbing in the following two weeks. In their follow-up report in 
1975 (14) there was only 1 catheterization-related death of 41 patients 
with LMCA lesions catheterized from May 1971 to November 1973 (2.4%). 
They attributed this dramatic improvement to a change in technical ap¬ 
proach to patients suspected of having main left lesions. They found 
that the best initial approach was to opacify the left coronary sinus 
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non-specifically and, if further definition is necessary, to slowly and 
carefully advance a preformed catheter into the left coronary ostium, 
leaving the catheter in place only for the injection of dye. Several 
other workers reported similarly high mortalities associated with angio¬ 
graphy prior to such technical changes (17,18,47-49). Others, particularly 
in more recent reports had a mortality of catheterization of 2% or less 
(8,18-21,28,29,50). 
The cause of myocardial infarction or death resulting from coronary 
arteriography is not readily apparent at post-mortem examination. Bassan 
and associates, however, (51) made measurements of peripheral coronary 
pressure through an arteriography catheter in the left coronary ostium 
and simultaneous coronary sinus blood flow in several patients with CAD. 
Only the patient with LMCA stenosis experienced a dramatic fall in flow 
and pressure when the angiographic catheter was introduced into the ostium. 
It was concluded that coronary arteriography might well jeopardize a pre¬ 
existing tenuous hemodynamic situation and thus lead to a high catheter¬ 
ization-related mortality rate. 
Comparison to Overall Group with Coronary Artery Disease 
Prior to studies specifically relating to LMCA disease, extensive 
investigations had been made to document the natural history of coronary 
disease in general. For the most part these studies consisted of patient 
populations with angina pectoris treated medically and followed for one 
to seven years in the period prior to the advent of bypass surgery at the 
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involved institution. Efforts to relate mortality rate to risk factors, 
many of which are interrelated, were extensively made. In all of these 
reports, prognosis appears to relate most strongly to the number of hemo- 
dynamically compromised coronary vessels (>.70% luminal narrowing) (8-13) . 
A detailed analysis of these studies is not within the scope of this paper, 
but a summary of combined results is displayed in Table 3 for comparison 
to the left main subgroup. Mean annual mortality for patients with single 
vessel disease was 2.8% in these reports. Patients with double and triple 
vessel involvement had a much poorer prognosis with annual mortality rates 
of 7.7% and 13.0%, respectively. 
When these figures are compared to the cardiac mortality for left main 
stenosis, several features are salient. The prognosis for LMCA disease is 
poorer than for single and for double vessel obstruction at least up to 5 
years after diagnosis. Expected mortality for LMCA obstruction in general 
is also higher than for triple vessel disease for the first 2 to 3 years 
following diagnosis, at which point the expected mortality for the two 
groups is roughly equal. We caution that these statements are oversimpli¬ 
fications, as other factors influencing prognosis have not been considered. 
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Table 3 
Reference Investigator No. of 
Patients 
Cardiac Average 
Deaths Follow-up 
(Months) 
Annual 
Mortality 
Rate (%) 
SINGLE VESSEL DISEASE 
8 Bruschke et al, 
1973 
202 29 84 2.6 
22 Oberman et al, 
1972 
46 2 20 2.6 
10 Lichtien et al, 
1972 
83 8 32 3.6 
11 Moberg et al, 
1972 
84 17 84 2.9 
12 Slagle et al, 
1972 
20 1 48 4.0 
13 Friesinger et al, 
1970 
TOTAL 
32 
467 
1 
58 
54 
65 
0.7 
2.8 
a=0.71 
DOUBLE VESSEL DISEASE 
8 Bruschke et al 233 88 70 6.4 
22 Oberman et al 50 13 22.7 13.7 
10 Lichtien et al 62 11 32.0 6.7 
11 Moberg et al 82 36 84.0 6.3 
12 Slagle et al 26 5 15.0 15.4 
TOTAL 453 153 59 7.7 
a=2.9 
TRIPLE VESSEL DISEASE 
8 Bruschke et al 118 65 84 9.6 
22 Oberman et al 52 14 19.3 16.7 
10 Lichtien et al 86 29 32.0 12.6 
11 Moberg et al 34 24 84.0 10.1 
12 Slagle et al 48 12 15.0 20.0 
TOTAL 338 144 51 13.0 
o=3.73 
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Prognostic Spectrum of Left Main Stenosis: 
Several investigators have attempted to subdivide the left main group 
into categories with different prognoses (16,26,27). Takaro and co-workers 
(16) in interpreting the results of the VA cooperative randomized study in 
1976 characterized a "high risk" group (poorer prognosis without surgery 
and higher surgical risk) consisting of patients with left main stenosis 
plus right coronary obstruction of >70%, plus some abnormality of left 
ventricular function. Left ventricular function was considered "abnormal" 
if any one of the following parameters was present: cardiac enlargement, 
abnormality of left ventricular contraction, elevation of left ventricular 
end-diastolic pressure (EVEDP) above 15mm Hg, or left ventricular ejection 
fraction (EF) <50%. There was a 30% mortality rate in this group of 30 
medically treated "high risk" patients in the first six months, 40% mortal¬ 
ity by 12 months, and 45% by 18 months, compared to 20%, 29%, and 32% 
mortality in the same intervals for the overall group of 53 medically 
treated LMCA patients. 
Other authors have attempted to refine prognostic ability based on 
extent of LMCA narrowing. Conley and colleagues (26) followed long-term 
survival in 163 consecutive medically treated patients with 50 to 70% 
left main stenosis and 98 patients with 70% or greater LMCA stenosis and 
*3.10 d 
calcul ^ survival rates up to 3 years. The vast majority of patients in 
both groups had three-vessel disease. Figure 1 is taken from their re¬ 
port, illustrating a statistically significant higher cumulative survival 
rate among patients with 50 to 70% stenosis compared to those with >707o 
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narrowing of the LMCA. 
Figure 1: (from Conley et al: Circulation 57: 950, 1978) 
Three year survivals were found to be 66% for the group with less 
severe obstruction compared to 41% (p<.05). The authors, in addition, 
outlined baseline characteristics they found to be significant predictors 
of one year mortality among patients with _>70% left main stenosis: history 
of congestive heart failure (CHF), chest pain at rest, cardiomegaly on 
chest x-ray, ST-T wave changes on the resting electrocardiogram (ECG), 
and catheterization parameters indicative of left ventricular dysfunction 
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(abnormal left ventricular contraction, LVEEP >15ram Hg, and arterio-venous 
oxygen difference >5.5 vol.%): 
Table 4. (From Conley MJ, et al: Circulation 57: 950, 1978) 
One year survival 
in pts with 70% 
LMCA obstruction 
Present Absent 
History of congestive heart failure 50% 81% 
Chest pain at rest (NYHA Class IV) 62% 85% 
Resting ST-T wave changes 61% 83% 
Cardiomegaiy on chest x-ray 50% 78% 
Abnormal left ventricular contraction 61% 95% 
Left ventricular end-diastolic pressure >15mm Hg 50% 81% 
Arteriovenous oxygen difference >5.5 vol% 50% 80% 
They then characterized low and high risk subgroups of patients with _>70% 
LMCA obstruction based on four noninvasive descriptors: CHF, chest pain at 
rest, cardiomegaiy on chest x-ray, and ST-T wave changes on resting ECG. 
Thirty-five patients had none or only one of these descriptors and were 
considered "low risk", and 63 had more than 1 descriptor present and were 
considered "high risk". Survival at each interval up to 3 years was signi¬ 
ficantly higher for the low risk subgroup than for the high risk subgroup 
with 1 year survivals of 97% and 59% and three-year survivals of 74% and 
25%, respectively. 
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Among the catheterization parameters studied, patients with abnormal 
left ventricular contraction pattern, elevated arteriovenous oxygen differ¬ 
ence, and elevated left ventricular end-diastolic pressure, had signifi¬ 
cantly lower one-year survivals. 
Another large series of medically treated patients with LMCA disease 
was reported in 1975 by Lim and associates (27). They also examined the 
relationship between degree of left main narrowing and long-term survival, 
but were unable to demonstrate a significant correlation. This is in dis¬ 
agreement with the results of Conley et al and may be due to the inadvertant 
patient selection by Lim et al who excluded all medically treated patients 
who underwent surgery within five years of the date of catheterization. 
These patients could possibly have been "lower risk", with only 50 to 70% 
stenosis and had a lower mortality. The authors did, however, identify a 
number of prognostically important factors for 5-year survival including 
severity of angina pectoris, history of congestive heart failure, electro¬ 
cardiographic abnormalities, evidence of left ventricular hypertrophy, 
three-vessel disease, and decreased left ventricular contractility. These 
findings, like the results of Cohen et al (14), parallel the descriptors 
of the Conley study (26). 
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Noninvasive Indicators of LMCA Disease 
In response to the high risk associated with catheterization for 
patients with LMCA stenosis, effort has been made to identify noninvasive 
descriptors that might suggest the presence of this lesion. Cohen and 
Gorlin (47) examined a large number of historical, physical, and labora¬ 
tory factors including history of myocardial infarction, hypertension, the 
nature, duration, radiation, severity and pattern of angina pectoris, 
symptoms associated with chest pain such as dyspnea and faintness, carbo¬ 
hydrate and lipid abnormalities, electrocardiographic evidence, and, where 
possible, the double Master’s two-step exercise test (52,53). They found 
no specific historical, physical or laboratory feature that differentiated 
the 32 patients in the LMCA subgroup from the larger population of CAD 
patients. A marked ischemic response to the double Master’s test, however, 
was seen in 82% of the LMCA patients, with more than 2mm R-ST segment de¬ 
pression at adequate rate response. This compares with reports of 34% of 
patients with CAD, most commonly triple-vessel disease, exhibiting this 
degree of response (54). While there were false positives, their results 
suggested that all patients with marked ischemic response to the Master's 
test are suspect for either LMCA disease or proximal disease of all three 
major coronary vessels. Kisslo and co-workers confirmed these findings 
(21), reporting that in patients with three-vessel involvement, the addi¬ 
tional presence of a LMCA lesion significantly increases the likelihood 
of a positive exercise test. Khaja et al (19) reported a similarly 
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high percentage of LMCA patients with markedly ischemic exercise res¬ 
ponses (77%) . 
The intermediate coronary syndrome and myocardial infarction have not 
been found to be more common in patients with LMCA lesion despite the large 
amount of myocardium endangered. Several studies of patients with the in- 
\ 
termediate syndrome report only 11-12% frequency of LMCA stenosis (55-57). 
This is only slightly higher than the above noted frequency of LMCA stenosis 
in the general CAD population. 
The diagnosis of LMCA disease, thus, ultimately depends upon coronary 
angiography, but may be suggested by a markedly ischemic exercise response. 
Treatment of LMCA Obstruction: Medical vs Surgical 
Extensive investigations have been attempted by many authors comparing 
survival rates of patients with significant LMCA stenosis treated medi¬ 
cally and surgically (16-18,20-23,25,28,33,50). Table 5 displays a summary 
of the results of major studies. Interpretation of the figures is indeed 
difficult as many of the reports contain strong biasing resulting from 
selection of surgical candidates, inadequate or selective patient follow¬ 
up, or a combination of these problems. In addition heterogeneity of 
patient populations, variation in degree of left main obstruction, in¬ 
volvement of the right coronary artery (RCA), variation in surgical techni¬ 
que, and refinement in surgical ability over the years makes comparative 
analysis among reports from different centers of questionable validity. 
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Farinha et al (17) compiled a large series of impressive surgical 
results with a 4-year survival reportedly 86%. In their group of 297 
patients with left main narrowing of >_50%, 30 patients did not undergo 
the bypass procedure either because they died at angiography, had ex¬ 
tensive involvement of the distal coronary tree, precluding surgery, 
refused surgery, or had other contraindications. The non-surgical group 
had a 50% 5-year survival, which is consistent with the results of others 
described above. Talano et al (25) attempted to avoid biasing by elimina¬ 
ting from the comparative medical group those patients considered inoper¬ 
able. Of risk factors compared for the operable and surgical groups, 
however, two were found more prevalent in the medically treated "operable" 
group than the surgical group: proximal RCA obstruction (71% vs 53%) and 
left ventricular contraction abnormalities (57% vs 44%). Their results 
show improvement in survival for the surgical groups, the significance of 
which is uncertain. Sung and colleagues (29) published results of 19 
LMCA patients undergoing bypass grafting showing an 89% surviving per¬ 
centage at 18 months compared to 55% for the 11 nonsurgically treated 
patients. The authors admit a surgical biasing in this study and sub¬ 
divide their nonsurgical group into those "suitable" and "unsuitable" for 
surgery based on adequacy of distal coronary vasculature. A high per¬ 
centage of those patients felt to be unsuitable for surgery died in the 
first year (67%), and a comparison of patients considered surgical candi¬ 
dates treated medically with those treated surgically yielded no differ¬ 
ence in survival rates for the two groups. Similarly, Campeau et al (32) 
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published the results of a large series of LMCA patients treated medi¬ 
cally and surgically showing significant improvement in long-term survival 
with surgery. Their unoperated cohort, however, had lower ejection frac¬ 
tions and higher left ventricular end-diastolic pressures than the oper¬ 
ated group. 
Three studies approached the evaluation of treatment for left main 
obstruction using comparable groupings (16,20,22). Takaro et al (16) in 
the VA prospectively randomized study compared a group of 53 LMCA patients 
treated medically to 60 LMCA patients treated surgically in 30 cooperating 
VA hospitals. The treatment groups were established prospectively and 
had equal distributions of all historical, physical, laboratory, angio¬ 
graphic, and hemodynamic parameters. Statistically significant cumulative 
survival rate differences were found at 18 months, 2 years, and 20 months. 
Surgical patients at these times had 85%, 85%, and 85% surviving percent¬ 
age, respectively, compared to 68%, 68%, and 65% in medically treated 
patients. The results of Oberman et al from the University of Alabama 
(22) show similarly improved survival rates for surgically treated patients 
up to 2 years after surgery in comparable groupings. In their comparison 
the authors avoided biasing by eliminating from consideration patients 
judged unsuitable for operation because of diffusely hypokinetic ventricles, 
ejection fractions of less than 0.20, or diffuse distal disease of the 
three major coronary arteries. DeMots et al (20), in analyzing the re¬ 
sults of a series of LMCA patients treated medically and surgically were 
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able to eliminate surgical biasing in a similar way. They, however, 
found no significant improvement in long-term survival with surgery. 
Attempts have been made to identify a subgroup among patients with 
LMCAD that might benefit more definitely from surgical management. 
Takaro et al (16) identified a "high risk" subgroup with poorer prognosis 
than the overall LMCAD group when treated medically. As described above, 
these were patients with significant LMCA obstruction plus significant 
right coronary artery obstruction plus some abnormality of left ventri¬ 
cular function. A comparison of survival curves of 30 high risk patients 
treated medically and 34 high risk patients treated surgically consistently 
indicated statistically significant higher survival with surgical manage¬ 
ment. At 6 months, 12 months, 24 months, and 36 months after surgery or 
diagnosis, the surgical group had 88%, 88%, 88%, and 83% surviving per¬ 
centage, respectively, compared to 70%, 60%, 55%, and 55% at the same 
follow-up intervals for the medical group. Even discounting left ventri¬ 
cular function, patients in this study having both a left main lesion 
and significant right coronary arterial disease fared better surgically. 
Similar results were reported by Campeau et al (32) who found a 
significantly higher survival rate with surgical treatment for LMCA 
patients with additional RCA obstruction ('triple-vessel disease") than 
for medical treatment. Their group of LMCA surgical patients who did not 
have significant RCA disease did not have a statistically significant in¬ 
crease in survival. 
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While the quality of work in this area has been variable, it 
appears likely that surgery does improve long-term survival for patients 
with LMCA lesions. If disease of the RCA is additionally present, 
surgery is more likely to be of value in prolonging life. Furthermore, 
if there is RCA obstruction plus some degree of left ventricular dys¬ 
function, surgery will most likely be of benefit for prolonging survival. 
Assessment of the Quality of Life: 
The proportion of patients free from angina pectoris, congestive 
failure, or myocardial infarction was consistantly higher in all reports 
for survivors of surgery, as compared to medically managed patients (16-18, 
20-23,25,28,33,50). In surviving surgically treated patients whose angina 
was not completely relieved, the relative frequency and severity of symp¬ 
toms was reportedly decreased for the majority of patients in all studies. 
In addition, increase in exercise tolerance has been reported for survivors 
of surgery for LMCA obstruction. McConahay et al (31) reported that 74% 
of 54 patients having abnormal preoperative stress tests converted to 
normal after surgery. Zeft et al (28) also reported improvement in exer¬ 
cise tolerance using supine bicycle ergometry in a number of their patients. 
Their results are difficult to interpret, however, as only 6 of 56 LMCA 
patients undergoing bypass surgery were tested both pre- and post-opera- 
tively, all 6 showing marked improvement after surgery. 
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Operative Risk for LMCA Disease: Mortality and Perioperative Myocardial 
Infarction:   
Early results of surgery for LMCA obstruction showed a very high 
operative mortality for this subgroup. Surgical mortality ranged in 
many centers from 10 to 31% for LMCA patients before refinements in 
technique were instituted (Table 6). 
Table 6. 
Reference 
Early Results for Operative Mortality in LMCA Disease 
Investigator Dates of Surgery No. of 
Pts. 
Operative 
Mortality (%) 
16 Takara et al. 1970 - 1972 20 25 
20 DeMots et al 1967 - 1974 26 15.4 
28 Zeft et al 1970 - 1971 56 10.7 
57 Cooley et al 1970 - 1972 82 25.6 
58 Oldham et al 1969 - 1972 26 31 
TOTAL: 210 
AVERAGE: 21% 
o: 7.4 
With increasing surgical experience and technical improvements operative 
morbidity and mortality improved steadily since the early 70*s for bypass 
procedures in general and markedly for bypass procedures in patients with 
left main obstruction (57-67) . Table 7A summarizes the results of oper¬ 
ations performed in recent years and presents approximate current esti¬ 
mates of expected operative mortality and incidence of perioperative 
myocardial infarction (MI) in the LMCA subgroup. For comparison, a summary 
of reported results for surgical mortality and perioperative 
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MI rates in major centers for the overall CAD patient population is pre¬ 
sented in Table 7B. 
Table 7A: Risks of Bypass 
excluded) 
Surgery for LMCA Stenosis (combined procedures 
Ref. Investigator Dates of No. of Operative Perioperative 
Surgery Pts Mortality (%) MI (%) 
14 Cohen et al 1971-1973 41 11 
16 Takara et al 1970-1971 20 25 TO Q 
(VA Coop Study) 1971-1974 45 7 12. J 
17 Farinha et al 1970-1975 267 7 7.9 
22 Oberman et al 1966-1975 149 3.0 
87 6.9* 
25 Talano et al 1968-1974 89 11 
28 Zeft et al 1970-1971 56 10.7 
29 Sung et al 1972-1974 19 5.3 
30 Garcia et al 1974-1976 18 11 
31 McConahay et al 1971-1975 146 1.4 
32 Campeau et al 1972-1976 144 6.2 
35 Langou et al 1974-1975 19 37 
TOTAL NO. OF PATIENTS: 994 438 
AVERAGE: 6.6% 8.0% 
a: 4.1 6.6 
*figure does not include operative deaths who infarcted. 
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Table 7B: Risks of Bypass Surgery for CAD-Overall Population 
(combined procedures excluded) 
Ref. Investigator Dates of 
Surgery 
No. of Operative 
Pts Mortality (%) 
Perioperative 
MI (%) 
59 Cooley et al 1971-1972 1289 7.1 14.1 
62 Sheldon et al 1974 1947 1.6 4.7 
63 Anderson et al 1973 134 1.5 
65 Kouchoukos et al 1970-1975 1590 1.6 
1974 315 3.5 
66 Morris et al 1970-1971 480 6.5 10 
67 Brymer et al 1974-1975 151 4.6 
68 Geha et al 19 73-1974 128 4 
1971-1974 213 5.2* 
69 Hall et al 1972 217 5.1 
1968-1972 1105 14.1 
70 Langou et al 1974-1975 168 4.7 23 
TOTAL NO. OF PATIENTS: 5988 5517 
AVERAGE: 3.5% 9.7 % 
a: 2.4 5.0 
*Figure does not include operative deaths who infarcted. 
The average operative mortality in these series of patients with LMCA 
stenosis was 6.6% with a range of 1.4% to 11% in various centers performing 
bypass operations since 1971. This compares with 3.5% operative mortality 
rate for the CAD population in general for operations performed since 1971 
in major centers (range: 1.5 to 7.1%). 
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It is difficult to define the precise role of the left main lesion 
itself in influencing this two-fold increase in risk for operative mortal¬ 
ity. Studies addressing factors correlating with mortality for bypass 
procedures have identified 4 high risk predictors and 6 factors of lesser 
importance for operative mortality. Mundth and Austen (71) in an excell- 
entreview of this subject found a consistently high correlation in the 
literature of left ventricular (LV) dysfunction, recent myocardial in¬ 
farction, combined surgical procedures, and experience and skill of the 
surgical team to operative mortality rate (57,64-66,71-78). Less consis¬ 
tent correlation with mortality was found for age, severity of angina, the 
number of vessels involved, the number of vessels grafted, previous (old) 
myocardial infarction, and acute myocardial ischemia (57,64-66,71-79). 
(Table 8). 
Table 8: (after Mundth and Austen: N 
Risk Factors for Operative Mortality 
High Risk Correlates 
Left ventricular failure: 
abnormal left ventricular 
angiogram with hypokinesis, 
akinesis, or aneurysm 
Ejection fraction <0.20. 
LVEDP > 18mm Hg 
Mitral insufficiency. 
Recent myocardial infarction 
Combined surgical procedures 
Surgical experience and skill 
Engl J Med 293: 13, 1975.) 
in Coronary Bypass Grafts_ 
Factors of Lesser Influence 
Age 
Severity of angina 
No. of vessels involved 
No. of grafts involved 
Previous Infarction (old) 
Acute myocardial ischemia 
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A high percentage of patients with LMCA stenosis also have a majority of 
these high and low risk correlates. Table 9 compiles the baseline data 
of several series of patients with LMCA stenosis of _> 50%. The average 
incidence of left ventricular dysfunction associated with this lesion 
was 76%. This is approximately twice the average incidence of LV dys¬ 
function found among the general CAD population undergoing bypass surgery 
(57,65,66,80,81). In addition, 79% of patients with LMCA lesions have 
significant disease of the right coronary artery. About half of the 
patients in the LMCA subgroup have severe angina (New York Heart Associ¬ 
ation Class III-IV or "unstable"angina), and about half have had a myo¬ 
cardial infarction prior to angiography and/or surgery. Finding a higher 
operative mortality for the LMCA subgroup, then, might well be the result 
of this high frequency among these patients of a number of factors that 
increase the operative mortality, and in particular the presence of left 
ventricular dysfunction. It is reasonable to say, however, that regard¬ 
less of the specific etiology, patients with LMCA lesions have an associ¬ 
ated high mortality rate at bypass surgery when compared to the overall 
group woth coronary artery disease. 
Evaluation of the incidence of perioperative transmural myocardial 
infarction occurring during or in the period following bypass procedures 
have been complicated by several factors in various reported series. As 
with operative mortality, results depend largely upon patient selection 
in a particular institution. 
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Table 9 Incidence of Operative Risk Factors Among Patients with _> 50% 
LMCA Stenosis 
Ref Investigator No. of LV Previous Severe +RCA 
Pts. Dysfunction MI Angina 
14 Cohen and Gorlin 73 >78% 36% 73% 
16 Takaro et al 113 66% 56% 62% 83% 
18 Lavine et al 30 86% 63% 37% 97% 
20 DeMots et al 58 24% 45% 83% 
22 Oberman et al 179 39% 65% 86% 
25 Talano et al 145 76% 66% 66% 
27 Lim et al 141 28% 62% 
28 Zeft et al 56 75% 66% 
29 Sung et al 39 90% 57% 80% 85% 
31 McConahay et al 176 41% 92% 
32 Campeau et al 311 50% 32% 
TOTAL NO. OF PATIENTS: 400 1120 1248 69 3 
AVERAGE: 76% 43% 59% 79% 
a: 7.4 10.0 19.8 9.2 
Abbreviations: 
LV dysfunction=the presence of abnormal LV angiogram or EF <0. 20, or 
LVEDP >18mm Hg, or mitral insufficiency. 
Previous MI=history of myocardial infarction 
Severe angina=New York Heart Association Class III-IV or "unstable" 
+RCA=LMCA stenosis + >70% obstruction of RCA 
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Furthermore, and perhaps more importantly, figures vary according to 
the method of detection of myocardial infarction employed and the diligence 
of the search carried out by the investigators (35,70). Assad-Morell and 
co-workers (82) in assessing the incidence of perioperative transmural 
myocardial infarction following bypass surgery compared post-operative 
elevations of serum glutamic oxaloacetic transaminase (SGOT) and creatine 
phosphokinase (CPK) to the development on serial electrocardiograms (ECG) 
of new pathologic Q waves (83) . Sixty-one of their group of 500 patients 
were found to have SGOT values of >100 u/liter on the first postoperative 
day. Only 48 percent (29 patients) of these 60 had ECG evidence of trans¬ 
mural MI, and of the 48 patients with ECG evidence of infarction, only 60% 
had SGOT values of >100 u/liter on the first postoperative day. Consider¬ 
ation of CPK values did not improve discrimination, and serum enzyme values 
on the second and third postoperative days demonstrated no correlation to 
ECG evidence. Alderman and colleagues (84) compared post-operative ele¬ 
vations of CPK, SGOT, and lactic dehydrogenase (LDH) to ECG evidence of 
transmural MI following bypass surgery in 112 consecutive patients. 
Despite establishing 90th percentile levels for enzyme values after 
surgery as an index for suspected infarction, correlation in specific 
cases to ECG evidence was variable. The authors concluded that non¬ 
specific cardiac enzyme testing could not provide a dichotomous separation 
between patients with and without ECG evidence of infarction. Marlon and 
Quinn (85) compared results of Technetium-99m pyrophosphate scans with 
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CPK, SGOT, and LDH testing as well as postoperative serial ECG’s in 28 
survivors of bypass procedures. They found 50% of the survivors to have 
positive scans, 89% to have significant enzyme elevations, and only 21% 
to have new pathological Q waves on serial electrocardiograms. 
While quantitation of the isoenzymes of creatine phosphokinase has 
been used to document acute myocardial infarction in nonsurgical patients 
(86), limited work has specifically addressed the use of CPK fractionation 
for detection of perioperative myocardial infarction following bypass pro¬ 
cedures. Isoenzyme recognition of acute myocardial necrosis is based on 
the uniquely high concentration of the CPK-MB molecular form in human 
cardiac tissue and its absence in normal serum. Dixon et al (87) in 1973 
were the first to apply this principle to the recognition of acute myo¬ 
cardial infarction following surgery. They compared post-operative ele¬ 
vations of the CPK-MB isoenzyme in a group of 20 patients undergoing non¬ 
cardiac operations and in a group of 100 patients having coronary artery 
bypass surgery with the appearance of new pathologic Q waves on ECG. Of 
the 20 patients undergoing noncardiac operations, none demonstrated ECG 
changes of acute MI, and 1 had an elevated CPK-MB fraction. This patient 
died during the post-operative period and myocardial infarction was con¬ 
firmed at autopsy. Of the 100 patients undergoing coronary bypass graft¬ 
ing, 49 had no appearance of CPK-MB, and none of these had new Q waves 
on ECG. In 21 of the 100, both CPK-MB and new pathologic Q waves on ECG 
appeared postoperatively. The mean duration of detectable CPK-MB in the 
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serum of these patients was 31 hours. In the remaining 30 patients 
CPK-MB was detected without ECG evidence of acute myocardial infarction. 
O'Rourke and co-workers (88) also found a significant correlation of 
elevated CPK-MB isoenzyme to new pathologic Q waves on ECG in their 28 
patients undergoing bypass surgery. As in the Dixon study (87) a higher 
percentage of patients had positive CPK-MB results than significant ECG 
changes. Righetti et al (89) studied 41 patients before and after bypass 
surgery utilizing serum CPK-MB isoenzyme measurements, Technetium-99m 
pyrophosphate scans, and the 12-lead ECG. They established an upper 
limit of "normal" for CPK-MB released after uncomplicated bypass surgery 
and compared the results of these three techniques. All 6 patients who 
had new Q waves on electrocardiogram had above-"normal" CPK-MB levels, 
and 5 of these had positive scans; five patients with "ischemic" ECG's 
and no new Q waves also had positive scans and high CPK-MB levels; and 6 
patients with no ECG changes had high CPK-MB results but negative scans. 
The authors concluded that: 1.) new Q waves on ECG underestimate the in¬ 
cidence of myocardial damage after coronary artery surgery; 2.) CPK-MB 
measurements alone overestimate the incidence of infarction; and 3.) A 
combination of the three techniques provides the best means of detecting 
myocardial infarction after bypass surgery. This statement represents an 
accurate summary of the current status of the detection of myocardial in¬ 
farction occurring during or immediately following bypass surgery. Most 
workers to date have employed the 12-lead electrocardiogram using the Q 
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wave criterion to follow their post-operative patients. 
In table 7A and 7B are displayed the combined results for occurr¬ 
ence of myocardial infarction in the perioperative period (up to 30 days 
after surgery) for coronary bypass surgery performed since 1970 in major 
centers for patients with LMCA lesions and for the general CAD population 
(14,16,17,22,25,28,30-32,35,57,61,62,64-69). All studies employed the 
electrocardiographic Q wave criterion for detecting myocardial infarction. 
As shown in the tables, the LMCA subgroup incurs MI In the perioperative 
period approximately as frequently as the overall CAD population under¬ 
going bypass surgery, 8 to 10%, We note that this is most likely a low 
estimate as diligence in looking for infarction was variable among the 
studies and the method of detection a conservative one. It is also noted 
that some investigators did not include in their calculations for peri¬ 
operative infarction those operative deaths that might have infarcted 
(see tables). 
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INTRA-AORTIC BALLOON PUMP; BACKGROUND AND PHYSIOLOGIC PRINCIPLES: 
To date the intraaortic balloon counterpulsation device (IABP) has 
been the most frequently used assist unit in the treatment of myocardial 
ischemia and low-output failure resulting from a variety of clinical 
disorders (36-44). The first reported clinical usage of the device was 
by KantR>witz and co-workers (90), who in 1967 used the IABP to success¬ 
fully support two patients in cardiogenic shock following myocardial in¬ 
farction. In the next 2 years several other investigators reported 
similarly successful results for the improvement and reversal of the 
clinical shock state following myocardial infarction in small numbers of 
patients (36,91). These early clinical successes led to rapid growth in 
the use of the IABP for a wide variety of disorders, and it is now esti¬ 
mated that over 22,000 such devices have been inserted worldwide (37). 
Standard procedure for insertion of the IABP is through a Dacron 
graft anastomosed end-to-side to the femoral artery. The balloon is in¬ 
flated in synchrony with the electrocardiogram and is timed to begin in¬ 
flation at aortic valve closure and deflate prior to aortic valve opening 
(38). This results in two important benefits; augmentation of coronary 
blood flow and reduction in heart work. 
IABP-induced augmentation of aortic root pressure during diastole 
occurs at a time when coronary vascular resistance is minimal. Coronary 
perfusion pressure is thereby elevated, resulting in improvement in 
blood flow and enrichment of oxygen supply to ischemic parenchyma. A 
number of workers have measured flow in a major patent coronary vessel 
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following acute ligation of another major coronary vessel and found a 
7 to 50% increase with the IABP (92-95), Coronary autoregulation has 
also been found to influence the degree of IABP augmentation. Powell 
and associates (95) pointed out that not until total coronary blood flow 
has been significantly reduced (to less than 50 ml/min/100 grams of left 
ventricle) during hypotension can the IABP augment flow. A detailed 
review of the physiologic parameters that influence the degree of augmen¬ 
tation to flow by the IABP exceeds the bounds of this paper, but it is 
recognized to be a complex interdependence of a number of factors including 
autoregulation, the extent of obstructive atherosclerotic disease, the 
size of the ischemic area, the extent of collateralization, and other 
hemodynamic and mechanical factors (38). 
The second benefit supplied by the IABP is reduction in required 
heart work and consequent reduction in oxygen consumption. The blood dis¬ 
placed by the balloon into the peripheral circulation reduces aortic end- 
diastolic volume and thereby reduces the impedance to ejection during the 
next contraction (reduction in "afterload"). Most workers have found a 
lessening of left ventricular systolic pressure by 4 to 20%, with an 
average reduction of 15% with the IABP (36,92,96,99). Furthermore, as 
afterload is reduced, it is predicted that the amount of shortening (or 
stroke volume) should increase as a result of the force-shortening rela¬ 
tionship of the left ventricle (100). Weber and Janicki (38) confirmed 
these predictions by measuring a 6 to 7% increase in stroke volume during 
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IABP assistance. This increase in shortening, the authors propose, leads 
to more complete emptying, a decline in end-systolic and end-diastolic 
volumes, and thus a reduction in preload. The IABP, then can assist the 
left ventricle by reducing both preload and afterload. 
Despite extensive demonstration of the clinical efficacy of the 
balloon for improving cardiac performance, limited work has focused on 
its effect on specific left ventricular hemodyamics and regional wall 
motion in clinical situations of ischemic heart conditions. This un¬ 
doubtedly is the result of the infeasability of performing multiple ventri¬ 
culograms in critically ill patients. Nichols and associates (101), how¬ 
ever, recently studied these parameters using multigated cardiac blood 
pool imaging (102) in 9 patients with unstable angina and 9 patients with 
acute myocardial infarction requiring IABP support. They found a signi¬ 
ficant reduction in end-diastolic and end-systolic volumes with the balloon 
in both situations of unstable angina and myocardial infarction. In 
addition, the IABP improved segmental contraction in all 7 unstable angina 
patients with regional wall motion abnormalities, but not in the 9 patients 
with acute myocardial infarction. The authors conclude that the IABP en¬ 
hances contraction of the ischemic but not infarcted myocardium and effec¬ 
tively improves ventricular function by reducing end-diastolic and end- 
systolic volumes. 
Prophylactic Balloon Counterpulsation for Cardiac Surgery 
Intraaortic balloon counterpulsation has been used prophylactically 
for patients with serious left ventricular dysfunction, severe ischemia, 
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and impending myocardial infarction undergoing cardiac surgery (37,39, 
42-44), Feola and colleagues (42) reported an improvement in operative 
mortality rate for bypass surgery from 8 to 4% in patients with poor 
left ventricular function (ejection fraction <0,30) when counterpulsation 
was instituted preoperatively and continued intra-and postoperatively for 
2 to 5 days. Others have reported a similar reduction in operative 
mortality for this subgroup undergoing bypass procedures (37,39). 
Increasing use of the IABP has also been reported for patients with 
unstable angina pectoris or impending myocardial infarction going to 
surgery for coronary grafting (37,39,103-105), with significant reduction 
in operative mortality. In addition, a recent article by Cooper et al 
(44) reported on the routine use of preoperative IABP in 26 patients with 
left main coronary stenosis. They had no mortality in this group and an 
8% incidence of perioperative myocardial infarction. While only minimal 
description was given of the preoperative risk profile of the group, their 
results suggest a promising area for more comprehensive evaluation. 
Risks of the IABP 
While the performance of a cardiac assist device is very important, 
assessment of associated side effects is of equal concern. Table 10 lists 
the complications that have been observed in patients on IABP assist in 
order of potential clinical severity: 
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Table 10. Complications of the IABP: 
Average incidence in 
Complication combined studies_ References 
Aortic damage 2.3% 37, 99, 106, 107 
Dissection of wall 
Laceration 
Subadventitial hematoma 
Vascular insufficiency of 
catheterized limb 3.7% 
37, 99, 106, 
Infection 4.2% 37, 107 
Groin wound 
Bacteremia 
Embolic phenomena 1.3% 37, 99, 106 
Platelet reduction (common, but very rare 99, 108, 109 
clinical sequelae) 
Red cell destruction (minimal) 100 
Balloon rupture and gas embolus (very rare) 37, 100, 106 
Ventricular rupture (not proved) 99, 100, 107 
Aortic dissection of varying severity has been reported in 1 to 5 % of 
patients receiving the IABP in various studies (37,99,101,106,107,108). While 
most workers report uneventful recovery, death resulting from balloon induced 
aortic damage has occurred. McEnamy et al reported 6 deaths (0.82%) related 
to aortic dissection secondary to improper device placement. 
Infection of the groin wound and bacteremia have been reported in 
approximately 3% and 1%, respectivelyjon the average in reporting centers 
(37, 107). The vast majority of these complications have been non-fatal. 
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A frequently encountered complication of intraaortic counterpulsation 
is vascular insufficiency of variable severity distal to the arteriotomy 
site of the catherized limb (37,99,106,107). Scheidt and associates (106) 
used the AVCO intraaortic balloon in 87 patients with cardiogenic shock 
and reported distal circulatory problems of varying severity in 13 patients 
(15%). Two had only transient distal arterial insuffiency which disappeared 
after removal of the device. Two others required ileo-femoral bypass after 
the balloon was removed, with good results. One patient had permanent arterial 
insufficiency of the leg, and two others developed leg neuropathies of vari¬ 
able severity and duration. Six patients died before a final outcome was appa¬ 
rent. Beckman and colleagues (107) reported limb ischemia in 16 of 173 patients 
(6%) receiving intraaortic balloon counterpulsation (AVCO balloon) as an 
adjunct to surgical or medical therapy from 1973-1976. Distal arterial insuff¬ 
iciency resolved in 12, resulted in gangrene of the toes in 1, leg gangrene 
in 2, and was the cause of death in 1 patient. McEnamy and co-workers (37) 
reported a 1.6% incidence of vascular insufficiency of variable severity in 
728 patients receiving the IABP from 1968 to 1976. While there was a 5.7% 
incidence of femoral thrombosis in this study, all of these patients were 
treated by local surgical procedures with no resulting cases of limb ischemia. 
Dunkman and associates (99) since 1972 have been routinely exploring balloon 
catherized vessels with a Fogarty catheter at the time of balloon removal, 
and in so doing have been able to reduce the incidence (and severity) of vasc¬ 
ular insufficiency to 2.5%. 
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Embolic phenomena resulting from balloon-induced thrombosis have been 
reported in approximately 1 to 5% of patients. Scheidt et al (106) had 1 
death attributable to a renal embolus associated with a thrombus on the surf¬ 
ace of the balloon in a patient who had not been anticoagulated and the 
balloon motionless on stand-by for many hours. McEnamy et al (37) reported 
a 1% incidence of peripheral emboli in their series of 728 patients. Dunkman 
et al (99) found no clinical evidence of emboli in their series but noted 
incidentally on post-mortem examination small testicula^hnd renal emboli 
/ 
in 2 patients (5%). 
A complication of the IABP that has been consistently cited is a re¬ 
duction in platelet count, occurring within the first 24 hours . Dunkman et 
al (99) reported a fall of 50% from prepumping levels in most patients. A 
return to normal levels occurred during a variable time period following 
removal of the balloon among these patients. DeLaria (108) and Madras (109) 
found similar results in animal studies. 
While the possibility of balloon rupture and gas embolism is always 
present, only 1 death has been reported (106), thought to be due to improper 
insertion of the device leading to rupture. McEnamy and associates reported 
a non-fatal case of a balloon gas leak among their 728 patients. 
A subdivision of IABP related complications into "minor" and "major" 
categories has been proposed by McEnamy and colleagues (37) according to 
whether the complication had caused either death, a second surgical procedure, 
abbreviation of IABP therapy, long-term morbidity, or prolongation of the 
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hospital stay. Table 11 is a compilation of complications classed in 
this manner encountered by several groups. 
Table 11. Incidence of Complications with the IABP 
Ref Investigator No. of 
Pts 
Overall 
Complications 
rate (%) 
Major 
Complications 
rate (%) 
37 McEnamy et al 728 21.6 8.8 
99 Dunkman et al 40 10 0 
106 Scheidt et al 87 21.8 8.0 
107 Beckman et al 273 13.5 4.0 
TOTAL 1128 19.2% 
0=3.9% 
7.3 % 
o=2.4% 
The average overall incidence of complications is 19.2% with a 7.3% in¬ 
cidence of major complication. 
While the IABP has successfully influenced patient recovery in many 
clinically settings, the risk of side effects is indeed non-trivial. 
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PATIENTS AND METHODS 
Data were collected prospectively on 91 consecutive patients shown 
to have greater than 50% obstruction of the left main coronary artery 
who underwent aortocoronary bypass grafting at Yale-New Haven Hospital 
from June 1975 through December 1977, 
Diagnostic cardiac catheterization consisted of pressure measure¬ 
ments, cardiac output determination, right anterior oblique left ventri¬ 
culogram for analysis of regional wall motion (110), mitral regurgitation, 
and ejection fraction [calculated according to the method of Greene (111)], 
and selective coronary cinearteriography, all performed by standard techni¬ 
ques. A greater than 50% stenosis of the left main coronary artery and a 
greater than 70% stenosis for other coronary arteries was considered signi¬ 
ficant. 
Coronary bypass surgery was performed within two weeks following 
angiography in all patients. All grafts to the left circumflex and right 
coronary arteries were performed using reversed autogenous saphenous veins. 
The left anterior descending artery was grafted using the left internal 
mammary artery (LIMA) in 37 patients, aorto-saphenous bypass (SVG) grafts 
in 45 patients, and double grafts using SVG and LIMA in 9 patients. 
Dissection of the left internal mammary artery from the chest wall and 
proximal anastomoses of saphenous vein grafts were accomplished without 
cardiopulmonary bypass. Distal anastomoses were performed on full cardio¬ 
pulmonary bypass using topical hypothermia at 28°C to 30°C with the 
heart in ventricular fibrillation. Aortic 
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cross-clamping was used only when a dry field could not be obtained by 
local occlusion of the coronary artery. Each distal anastomosis was 
probed near its completion to ensure that the anastomotic communication 
was wider than the grafted coronary artery. The left ventricle was vent¬ 
ed in all patients by a catheter passed through the right superior pulmo¬ 
nary vein or the ventricular apex into the left ventricular cavity. All 
blood aspirated into the extracorporeal circuit from the vent or cardiac 
suction lines was filtered through a millipore filter* * before being re¬ 
turned to the oxygenator**. Whole blood was transfused only if perfusate 
hematocrit fell below 25 percent, and serum potassium levels were care¬ 
fully monitored and appropriately adjusted. 
Definition of Variables Studied 
Operative mortality was considered to be in-hospital death within 4 
weeks of surgery. Perioperative MI was defined as myocardial necrosis 
occurring within 1 week postoperatively and identified by serial electro¬ 
cardiograms (ECG's), post-mortem examination, or both. Major operative 
complication was defined as surgically-related death or perioperative 
myocardial infarction. All patients had daily standard 12-lead electro¬ 
cardiograms from the day before surgery until the seventh postoperative 
day with the first operative tracing obtained upon arrival in 
* Swank Micro-Emboli Filter, Pioneer Filter Co., Beaverton, Oregon. 
**Temptrol Disposable Blood Oxygenator Model Q100, Bentley Laboratories 
Inc., Santa Anna, California; or Kolobine Disposable Membrane Oxygenator, 
Sci-Med, Minneapolis, Minnesota 
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the Surgical Intensive Care Unit. The criterion for acute myocardial in¬ 
farction was the development on serial ECG's of new significant pathologi¬ 
cal Q waves, equivalent to Class 1-1 and 1-2 of the Minnesota Code (112). 
New intraventricular conduction defects, new bundle branch blocks, in¬ 
creasing size of previous Q waves, ST segment or T wave changes without 
new pathological Q waves or elevations of CPK, SGOT, LDH, and CPK-MB iso¬ 
enzyme were not considered diagnostic of MI. Mortality of perioperative 
MI was considered to be death up to 4 weeks after coronary surgery. 
Statistical Methods: 
2 
Contingency table chi-square (x ) and multiple logistic regression 
model were used to analyze the data. A probability value <0.05 was con¬ 
sidered statistically significant. When information on a specific clinical 
characteristic of a patient was not available, that patient was excluded 
from analysis of the particular variable. 
Patient Groupings 
Thirty-five patients were treated pre-operatively with intraaortic 
balloon counterpulsation***, and these patients were classed in this study 
as Group A. Fifty-six patients did not receive the IABP and were classed 
as Group B. The individual clinical decision regarding the insertion of 
an IABP depended largely upon the clinical condition of the patient and 
***AVC0 Intra-aortic Balloon, Hoffman-LaRoche, Inc,, Cranbury, New Jersey. 
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the availability of an IABP, but maximal effort was made to assist 
patients with unstable angina with counterpulsation. When used, the 
IABP was introduced under local anesthesia in the Surgical Intensive Care 
Unit through the common femoral artery via an end-to-side 10 mm. dacron 
graft and advanced into the descending thoracic arota. When difficulties 
in balloon introduction were encountered or anticipated, a wire-guided 
central lumen balloon catheter (113) was introduced under direct fluoros¬ 
copy and pressure monitoring in the cardiac catheterization laboratory. 
Details of IABP introduction and management have been previously described 
(107). 
The IABP was removed either at bypass surgery or up to 48 hours 
postoperatively in the Surgical Intensive Care Unit in all cases. 
Demographic Characteristics: 
Table 12 displays parameters relating to the past medical history 
and physical examination of this group of 91 patients with left main 
stenosis. If a specific parameter was not known for a particular 
patient that patient was eliminated from consideration for that descrip¬ 
tor. History of congestive heart failure (CHF) was considered positive 
if the patient had past clinical history of dyspnea on exertion or had 
physical signs at examination. Family history was considered positive 
only if ischemic heart disease was present in an immediate family member 
before age 55. Hypertension was defined as present in the history if the 
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patient was being treated for hypertension or had repeated systolic pres¬ 
sures above 160mm Hg or diastolic pressures above 95mm Hg during admission. 
Peripheral vascular disease was considered present if there was a history 
of intermittent claudication or physical findings of decreased peripheral 
pulses or bruits. A patient was classed as having a positive smoking 
history if he smoked cigarettes daily for at least 1 year within 10 years 
of admission. Angina pectoris was graded according to the New York Heart 
Association (NYHA) functional classification (114): Class I = minimal 
limitation of activity - "ordinary" physical activity does not produce 
symptoms; Class II = slight limitation of ordinary activity - symptoms 
with severe exertion. Class III = marked limitation of ordinary physical 
activity - symptoms with mild exertion; Class IV = inability to carry on 
any physical acitvity without discomfort - symptoms may occur at rest. 
The pattern of angina was classed as "stable" if no change in the 
severity of symptoms was reported within the 6 month period prior to 
admission "progressive" if anginal symptoms were becoming more frequent 
or severe (change in NYHA Class), and "unstable" only if the patient ex¬ 
perienced chest pain at rest of at least 20 minutes' duration, refractory 
to medical therapy with 3-blockers and nitrates. We point out that this 
is a relatively rigorous definition of unstable angina corresponding to 
the "intermediate coronary syndrome", "pre-infarction angina", or "crescendo 
angina" used by other authors (103,115-118). Patients on propranolol were 
subdivided according to daily dosages above or below 160mg and according 
to the method of discontinuation before surgery (abrupt withdrawal 
cessation of propranolol without tapering within 24 hours of surgery). 
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Table 12, Demographic Characteristics: Medical History and Physical Exam 
Total Group A l (IABP) Group B i' (no IABP) 
No. of Patients 91 35 56 
AGE 
<55 34/91 (37%) 10/35 (29% 24/56 (43%) 
>55 57/91 (63%) 25/35 (71%) 32/56 (57%) 
SEX 
M 73/91 (80%) 31/35 (89%) 42/56 (75%) 
F 18/91 (20%) 4/35 (11%) 14/56 (25%) 
Previous MI 37/87 (43%) 16/35 (46%) 21/52 (40%) 
H/0 CHF 24/87 (28%) 10/35 (29%) 14/52 (27%) 
+ Family Hx 54/87 (62%) 22/33 (67%) 32/54 (59%) 
H/0 Hypertension 29/90 (32%) 10/35 (29%) 19/55 (35%) 
Peripheral Vascular Disease 24/91 (26%) 7/35 (20%) 17/56 (30%) 
Smoking 58/90 (64%) 21/34 (62%) 37/56 (66%) 
ANGINA 
Severity: Class I (NYHA) 2/91 (1%) 0/35 (0%) 2/56 (3%) 
Class II 14/91 (15%) 3/35 (9%) 11/56 (20%) 
Class III 22/91 (24%) 4/35 (11%) 18/56 (32%) 
Class IV 53/91 (58%) 28/35 (80%) 25/56 (45%) 
Pattern: Stable 22/91 (24%) 6/35 (17%) 16/56 (29%) 
Progressive 52/91 (57%) 16/35 (46%) 36/56 (64%) 
Unstable 17/91 (19%) 13/35 (37%) 4/56 (7%) 
PROPRANOLOL 
NONE 14/89 (16%) 1/35 (3%) 13/54 (24%) 
<160 QD 22/89 (25%) 6/35 (17%) 16/54 (30%) 
.>160 QD 53/89 (60%) 28/35 (80%) 25/54 (46%) 
PROPRANOLOL TAPERING 
No propranolol 14/75 (19%) 1/35 (3%) 13/40 (32%) 
Abrupt withdrawal 6/75 (8%) 1/35 (3%) 5/40 (12%) 
Tapered or discontinued 
>36 hours pre-op on IABP 53/75 (71%) 33/35 (94%) 22/40 (55%) 
Abbreviations: 
CHF=congestive heart failure 
F=female 
H/O=history of 
Hx=historv -46- 

It can be seen that the following variables were distributed approxi¬ 
mately equally between the 35 Group A and 56 Group B patients: age over 55, 
sex, history of previous MI, history of congestive heart failure (CHF), 
positive family history, history of elevated blood pressure, 
evidence of peripheral vascular disease, history of smoking, 
and propranolol dosage and tapering. Sixty-three percent of the population 
was over 55; 80% were male, 43% had a history of previous MI 28% had symp¬ 
toms of CHF; 62% had a positive family history; 26% showed signs of peri¬ 
pheral vascular disease; 64% had a positive smoking history; 60% had been 
on more than 160 mg. propranolol per day, and 8% had propranolol therapy 
abruptly stopped without tapering before surgery. 
Statistically significant differences between the two groups were 
found only in the severity and pattern of angina pectoris. Eighty percent 
of Group A patients had New York Heart Association (NYHA) Class IV angina, 
while only 45% of Group B patients had Class IV Symptoms (p<0.05). Un¬ 
stable angina was present in 37% of Group A patients compared to 7% of 
Group B patients (p<0.05). 
Similarly, radiologic, hemodynamic, and angiographic data are 
shown in Table 13. 
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Table 13. Demographic Characteristics: Chest X-ray and Cardiac Catheterization 
Total Group A (IABP) Group B (no IABP) 
Cardiac Enlargement 16/91 (18%) 6/35 (17%) 10/56 (18%) 
VESSELS DISEASED 
LMCA only 14/91 (15%) 2/35 (6%) 12/56 (21%) 
LMCA + RCA 77/91 (85%) 33/35 (94%) 44/56 (79%) 
EJECTION FRACTION 
_> 0.60 39/75 (52%) 14/29 (48%) 25/46 (54%) 
< 0.60 36/75 (48%) 15/29 (52%) 21/46 (46%) 
LVEDP 
< 12 mm Hg 31/84 (37%) 11/34 (32%) 20/50 (40%) 
> 12 mm Hg 53/84 (63%) 23/34 (68%) 30/50 (60%) 
Mitral Regurgitation 6/81 (7%) 2/35 (6%) 4/46 (9%) 
Abnormal Segmental 
wall motion 53/84 (63%) 25/34 (73%) 28/50 (56%) 
Abbreviations: 
LMCA=left main coronary artery 
LVEDP=left ventricular end-diastolic pressure 
RCA=right coronary artery 
+=positive 
A comparable distribution between the two groups can be seen for cardiac 
enlargement (CT ratio on chest x-ray >50%), abnormal ejection fraction 
(EF), elevated left ventricular end-diastolic pressure (LVEDP), evidence 
of mitral regurgitation, presence of triple vessel disease and of abnormal 
-48- 

segmental wall motion. Eighteen percent of the total population had 
cardiac enlargement; 48% had an EF of <0.60; 63% had LVEDP of > 12mm Hg; 
7% had evidence of mitral regurgitation; 85% had disease of the right 
coronary artery (RCA) in addition to the left system; and 63% had abnormal 
segmental wall motion on left ventriculogram. 
Table 14 displays operative data for the group. 
Table 14. Operative History 
Total Group A (IABP) Group B (no IABP) 
NO. OF GRAFTS PERFORMED 
1 1/91 (1%) 0/35 (0%) 1/56 (2%) 
2 26/91 (29%) 4/35 (11%) 22/56 (39%) 
3 56/91 (62%) 26/35 (74%) 30/56 (54%) 
4 7/91 (8%) 4/35 (11%) 3/56 (5%) 
DISEASED VESSELS NOT GRAFTED 
All grafted 61/91 (67%) 24/35 (69%) 37/56 (66%) 
One diseased vessel not 
grafted 30/91 (33%) 11/35 (31%) 19/56 (34%) 
Specifically: LAD 2/91 (2%) 1/35 (3%) 1/56 (20%) 
LCF 21/91 (23%) 6/35 (17%) 15/56 (27%) 
RCA 7/91 (8%) 4/35 (11%) 3/56 (5%) 
CPB TIME 
< 90 min. (") 38/91 (42%) 13/35 (37%) 25/56 (45%) 
> 90 min 
• 
53/91 (58%) 22/35 (63%) 31/56 (55%) 
ANOXIA TIME 
0 27/91 (30%) 11/35 (31%) 16/56 (29%) 
0-30" 27/91 (30%) 8/35 (23%) 19/56 (34%) 
31-60" 30/91 (33%) 11/35 (31%) 19/56 (34%) 
>60" 7/91 (8%) 5/35 (14%) 2/56 (4%) 
Abbreviations: 
LAD=left anterior descending coronary artery 
LCF=circumflex coronary artery 
RCA=right coronary artery 
CPB=cardiopulmonary bypass 
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An approximately equal distribution of patients receiving the IABP and 
those not was seen for number of diseased vessels not grafted (incomplete 
revascularization), cardiopulmonary bypass (CPB) time, anoxia time (aortic 
cross-clamping), and number of grafted vessels. Sixty-seven percent of 
the population had complete revascularization; 58% had a CPB time longer 
than 90 minutes; 41% had anoxia times greater than 20 minutes; and 69% 
received three or more grafts. No differences in operative parameters 
were seen between the two groups. 
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RESULTS 
Operative Mortality: 
Eight deaths occurred at or within 3 weeks of bypass surgery in the 
overall group of 91 patients with left main obstruction (9%). Two of 
these patients were in Group A, one of whom suffered an intra-operative 
myocardial infarction and could not be weaned from cardiopulmonary bypass, 
the other of whom had severe left ventricular failure and inability to 
come off bypass with no evidence of myocardial infarction. Six deaths 
occurred among Group B patients of whom 3 died in the operating room. 
Two of these three had evidence of intra-operative infarction while the 
third suffered severe left ventricular failure, preventing weaning from 
cardiopulmonary bypass. Two others had evidence of perioperative in¬ 
farction, succumbing within 2 weeks of surgery to the complications of 
post-operative cardiogenic shock. The sixth death in Group B was the 
result of low output left ventricular failure 21 days after surgery in 
a patient who had no evidence of perioperative myocardial infarction. 
An analysis of the incidence of operative death for previously 
reported or suggested risk factors is displayed in Table 15. 
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Table 15. Operative Deaths 
Total Group A 
(IABP) 
Group B 
(No IABP) 
INCIDENCE 8/91 (9%) 2/35 (6%) 6/56 (11%) 
AGE 
<55 1/34 (3%) 0/10 (0%) 1/24 (4%) 
>55 7/57 (12%) 2/25 (8%) 5/32 (16%) 
SEX 
M 5/73 (7%) 2/31 (6%) 3/42 (7%) 
F 3/18 (17%) 0/4 (0%) 3/14 (21%) 
PREVIOUS MI 2/37 (5%) 1/16 (6%) 1/21 (5%) 
h/0 CHF 1/24 (4%) 0/10 (0%) 1/14 (7%) 
ANGINA 
Severity: NYHA Class I 1/2 (50%) 1/2 (50%) 
Class II 1/14 (7%) 0/3 (0%) 1/11 (9%) 
Class III 2/22 (9%) 0/4 (0%) 2/18 (9%) 
Class IV 4/53 (7%) 2/28 (7%) 2/25 (8%) 
Pattern: stable 3/22 (14%) 0/6 (0%) 3/16 (19%) 
progressive 2/52 (4%) 0/16 (0%) 2/36 (6%) 
unstable 3/17 (18%) 2/13 (15%) 1/4 (25%) 
PROPRANOLOL 
none 2/14 (14%) 0/1 (0%) 2/13 (15%) 
<160mg QD 2/22 (9%) 0/6 (0%) 2/16 (12%) 
_>160mg QD 4/53 (7%) 2/28 (7%) 2/25 (8%) 
PROPRANOLOL TAPERING 
No propranolol 2/14 (14%) 0/1 (0%) 2/13 (15%) 
abrupt withdrawal 1/6 (17%) 0/1 (0%) 1/5 (20%) 
Tapered or discontinued 
on IABP 36 hours pre-op 
6/55 (11%) 2/33 (6%) 4/22 (18%) 
CARDIAC ENLARGEMENT 0/16 (0%) 0/6 (0%) 0/10 (0%) 
MITRAL REGURGITATION 0/16 (0%) 0/2 (0%) 0/4 (0%) 
ABNORMAL SEGMENTAL WALL MOTION 5/53 (9%) 2/25 (8%) 3/28 (11%) 
(Continued) 
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Table 15, Operative Deaths (continued) 
Total Group A 
(IABP) 
Group B 
(No IABP) 
EF 
^0.60 5/39 (13%) 1/14 (7%) 4/25 (16%) 
<0.60 2/36 (6%) 1/15 (7%) 1/21 (5%) 
LVEDP 
<12nim Hg 3/31 (10%) 1/11 (9%) 2/20 (10%) 
>12mm Hg 5/53 C9%) 1/23 (4%) 4/30 (13%) 
CPB TIME 
£90 min 0/38 (0%) 0/13 (0%) 0/25 (0%) 
>90 min 8/53 (15%) 2/22 (9%) 6/31 (19%) 
ANOXIA TIME 
0 2/27 (7%) 1/11 (9%) 1/16 (6%) 
0-30 min 4/27 (15%) 1/8 (12%) 3/19 (16%) 
31-60 min 2/30 (7%) 0/11 (0%) 2/19 (11%) 
> 60 min 0/7 (0%) 0/5 (0%) 0/2 (0%) 
VESSELS DISEASED 
LMCA only (RCA-NL) 0/14 (0%) 0/2 (0%) 0/12 (0%) 
LMCA + RCA 8/77 (10%) 2/33 (6%) 6/44 (14%) 
NO. OF GRAFTS PERFORMED 
1 0/1 (0%) - 0/1 (0%) 
2 4/26 (15%) 1/4 (25%) 3/22 (14%) 
3 4/56 (7%) 1/26 (4%) 3/30 (10%) 
>4 0/7 (0%) 0/4 (0%) 0/3 (0%) 
DISEASED VESSELS NOT GRAFTED 
All grafted 2/61 (3%) 0/24 (0%) 2/37 (5%) 
One diseased vessel not grafted 6/30 (20%) 2/11 (18%) 4/19 (21%) 
Specifically: LAD 1/2 (50%) 0/1 (0%) 1/1 (100%) 
LCF 4/21 (19%) 1/6 (17%) 3/15 (20%) 
RCA 1/7 (14%) 1/4 (25%) 0/3 (0%) 
EVIDENCE OF INFARCTION AMONG 
OPERATIVE DEATHS 5/8 (62%) 1/2 (50%) 4/6 (67%) 
Abbreviations: Propranolol=dosage of propranolol before surgical management; 
EF-ejection fraction; LVEDP-left ventricular end-diastolic pressure; 
NL=normal; LAD=left anterior descending; LCF-left circumflex ; 
RCA=right coronary artery; CPB=cardiopulmonary bypass 
MI=myocardial infarction; h/O=history of; CHF=congestive heart failur 
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In the overall group we found no significant association of operative 
mortality with age over 55, sex, severity of pattern of angina pectoris, 
previous myocardial infarction, history of congestive heart failure, pre- 
surgical propranolol dosage, propranolol tapering prior to surgery, 
cardiac enlargement, mitral regurgitation, abnormal segmental wall motion, 
abnormal ejection fraction, elevated LVEDP, operative anoxia time, or 
number of grafts performed. A significant association to operative 
mortality was seen, however, for CPB times of > 90 minutes and for in¬ 
complete revascularization (p<0.05). Fifteen percent of patients on 
CPB for longer than 90 minutes died compared to 0% of those with CPB 
times of <_ 90 minutes. In addition, 20% of patients with one obstructed 
vessel not grafted perished, compared to 3% of patients receiving com¬ 
plete revascularization to all diseased vessels. A suggested association 
to operative mortality was noted for patients with disease of the RCA 
(triple vessel disease). Ten percent of patients with additional disease 
of the RCA died compared to 0% of patients with LMCA lesions only. 
In the IABP group (Group A) there were 2 operative deaths (2/35,6%) 
compared to 6 in the group not receiving the IABP (6/56, 11%). This two 
fold difference, while suggestive, was not significant when tested statis¬ 
tically by contingency table chi-square analysis. We ran a similar 
analysis of reported risk factors for operative death against the results 
in each group. The numbers in Group A were small and no statistically 
significant associations to mortality could be demonstrated. In Group B, 
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as in the total population, CPB times of longer than 90 minutes were 
significantly associated with operative mortality (19% vs 0%, p<0.05)*~ 
Suggested associations to operative death in both groups paralleled the 
findings in the overall populations for triple vessel disease (Group A: 
6% vs 0%, Group B: 14% vs 0%) and incomplete revascularization (Group A: 
18% vs 0%, Group B: 21% vs 5%). 
Statistical analysis of the interdependence of risk factors and 
balloon usage was performed to determine if any combination was additive. 
No combination among the various permutations of factors was found to 
have an additive association with operative mortality. 
Perioperative Myocardial Infarction 
Perioperative myocardial infarction occurred in 15% of the total 
population of 91 patients with left main obstruction. The incidence 
of perioperative MI for previously reported or suggested risk factors 
is tabulated in Table 16. There was no association between perioperative 
infarction and age over 55, sex, severity or pattern of anginal pain, 
previous myocardial infarction, history of congestive heart failure, 
presurgical propranolol dosage, propranolol tapering, cardiac enlargement, 
mitral regurgitation, abnormal segmental wall motion, abnormal ejection 
fraction, elevated LVEDP, anoxia time, or incomplete 
revascularization. A significant association was seen between CPB times 
of >90 minutes (p<0.05) and suggested for the presence of triple vessel 
disease and for more than 3 grafts performed. Twenty-three percent of 
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Table 16, Patients Sustaining Perioperative Myocardial Infarction 
Total Group A Group B 
_ (IABP) (No IABP) 
INCIDENCE 14/91 (15%) 1/35 (3%) 13/56 (23%) 
AGE 
<55 5/34 (15%) 0/10 (0%) 5/24 (21%) 
>55 9/57 (16%) 1/25 (4%) 8/32 (25%) 
SEX 
M 11/73 (15%) 1/31 (3%) 10/42 (24%) 
F 3/18 (17%) 0/4 (0%) 3/14 (21%) 
PREVIOUS MI 3/37 (8%) 1/16 (6%) 2/21 (10%) 
h/0 CHF 1/24 (4%) 0/10 (0%) 1/14 (7%) 
ANGINA 
Severity: NYHA Class I 0/2 (0%) - 0/2 (0%) 
Class II 4/14 (29%) 0/3 (0%) 4/11 (36%) 
Class III 3/22 (14%) 0/4 (0%) 3/18 (17%) 
Class IV 7/53 (13%) 1/28 (4%) 6/25 (24%) 
Pattern: stable 5/22 (23%) 0/6 (0%) 5/16 (31%) 
progressive 8/52 (15%) 1/16 (6%) 7/36 (19%) 
unstable 1/17 (6%) 0/13 (0%) 1/4 (25%) 
PROPRANOLOL 
None 4/14 (29%) 0/1 (0%) 4/13 (31%) 
<160 QD 3/22 (14%) 0/6 (0%) 3/16 (19%) 
>160 QD 7/53 (13%) 1/28 (4%) 6/25 (25%) 
PROPRANOLOL TAPERING 
No propranolol 4/14 (29%) 0/1 (0%) 4/13 (31%) 
Abrupt withdrawal 0/6 (0%) 0/1 (0%) 0/5 (0%) 
Tapered or discontinued 7/55 (13%) 1/33 (3%) 6/22 (27%) 
on IABP 36 hrs. pre-op. 
CARDIAC ENLARGEMENT 0/16 (0%) 0/6 (0%) 0/10 (0%) 
MITRAL REGURGITATION 0/6 (0%) 0/2 (0%) 0/4 (0%) 
ABNORMAL SEGMENTAL WALL MOTION 6/53 (11%) 1/25 (4%) 5/28 (18%) 
EJECTION FRACTION 
2 0.60 7/39 (18%) 1/14 (7%) 6/25 (24%) 
< 0 .60 5/36 (14%) 0/15 (0%) 5/21 (24%) 
(continued) 
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Table 16. Patients Sustaining Perioperative Myocardial Infarction, (continued) 
Total Group A Group B 
__ (IABP) (No IABP) 
LVEDP 
< 12 6/31 (19%) 1/11 (9%) 5/20 (25%) 
> 12 7/53 (13%) 0/23 (0%) 7/30 (23%) 
CPB TIME 
< 90" 2/38 (5%) 0/13 (0%) 2/25 (8%) 
> 90" 12/53 (23%) 1/22 (5%) 11/31 (35%) 
ANOXIA TIME 
0 3/27 (11%) 0/11 (0%) 3/16 (19%) 
0-30" 4/27 (15%) 1/8 (13%) 3/19 (16%) 
31-60" 6/30 (20%) 0/11 (0%) 6/19 (32%) 
>60" 1/7 (14%) 0/5 (0%) 1/2 (50%) 
VESSELS DISEASED 
LMCA (RCA-NL) 1/14 (7%) 0/2 (0%) 1/12 (8%) 
LMCA+RCA 13/77 (17%) 1/33 (3%) 12/44 (27%) 
NO. OF GRAFTS PERFORMED 
1 0/1 (0%) - 0/1 (0%) 
2 5/26 (19%) 1/4 (25%) 4/22 (18%) 
3 7/56 (12%) 0/26 (0%) 7/30 (23%) 
1 4 2/7 (29%) 0/4 (0%) 2/3 (67%) 
DISEASED VESSELS NOT GRAFTED 
All grafted 9/61 (13%) 0/24 (0%) 8/37 (22%) 
One diseased vessel not 6/30 (20%) 1/11 (9%) 5/19 (26%) 
grafted 
Specifically: LAD 1/2 (50%) 0/1 (0%) 1/1 (100%) 
LCF 4/21 (19%) 1/6 (17%) 3/15 (20%) 
RCA 1/7 (14%) 0/4 (0%) 1/3 (33%) 
Abbreviations: LAD=left anterior descending; LCF=circumflex coronary artery; 
LMCA=left main coronary artery; LVEDP=left ventricular end-diastolic 
pressure; NL=normal; RCA=right coronary artery 
MI=myocardial infarction; h/0=history of; CHF=congestive heart failur 
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patients with prolonged CPB time infarcted compared to only 5% of those with 
CPB times of <90 minutes (p<0.05). Among patients with triple vessel 
disease there was a 17% incidence of perioperative HI compared with 7% 
among patients with LHCA obstruction only. Furthermore, twenty-nine per¬ 
cent of patients receiving 4 or more grafts infarcted compared to 12% with 
less than 4 grafts. 
Among the 35 patients in Group A there was only 1 perioperative 
infarction (3%) compared to 13 in the group not receiving the IABP (13/56, 
23%), p<0.05 . We again analyzed the results in each group for periopera¬ 
tive infarction and found a significant association in Group B with CPB 
times of >90 minutes (p<Q.05). In Group B greater than 3 grafts performed 
was a suggested risk for perioperative MI (67% vs 20%), as was the presence 
of triple vessel disease C27% vs 8%). The numbers in Group A were too 
small for quantitative analysis, but were qualitatively consistent with the 
findings in Group B and the overall populations. 
We again examined the interdependence of risk factors and IABP usage 
to determine the presence of any additive properties. Table 17 displays 
data showing an additive effect for the combination of triple vessel 
disease and not using the IABP and for the combination of prolonged CPB 
time and not using the balloon. 
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Table 17, Perioperative Myocardial Infarction 
Patients with IABP Patients without IABP 
Infarcting Infarcting p Value 
VESSELS DISEASED 
LMCA only 0/2 (0%) 1/12 (8%) NS 
LMCA + RCA 1/33 (3%) 12/44 (27%) <0.05 
CPB TIME 
< 90 min 0/13 (0%) 2/25 (8%) NS 
> 90 min 1/22 (5%) 11/31 (35%) <0.05 
Abbreviations: LMCA=left main coronary artery; IABP=intraaortic balloon pump; 
CPB-cardiopulmonary bypass; RCA=right coronary artery; 
NS-not significant 
The absence of triple vessel disease in patients receiving the IABP yielded 
a 0% infarction rate, while not using the balloon in the presence of triple 
vessel disease produced a 27% incidence of infarction. Similarly, 0% of 
patients receiving the balloon with CPB times shorter than 90 minutes 
suffered perioperative infarction compared to 35% of patients not counter- 
pulsated with prolonged CPB times. 
Table 18 delineates the location of detected perioperative infarctions 
and the relationship to nongrafted diseased coronary vessels. As noted 
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above, no significant correlation was found between incomplete revascular¬ 
ization and occurrence of transmural myocardial infarction in the peri¬ 
operative period. Specific correlations, however, were seen between 
location of infarcts and particular obstructed vessels not grafted. Of 2 
patients not receiving an LAD graft, one suffered an antero-septal in¬ 
farction. Of 21 patients not receiving a LCFX graft, 2 infarcted later¬ 
ally, 1 inferiorly,and 1 posteriorly. These areas approximated the 
regions supplied by the LCFX in the particular patients. The remaining 
17 patients did not sustain detectable (on ECG) transmural infarctions. 
The one patient with detectable transmural HI of the 7 with non-grafted 
obstructed right coronary arteries infarcted inferiorly. The mortality 
of periperative infarction was 36% (5/14), while patients not sustaining 
an MI had an operative mortality of 3.9% (3/77). 
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Table 18. Characterization of Infarcts 
Location 
ANTERO-SEPTAL 
Specifically: 
INFERIOR 
Specifically: 
LATERAL 
Specifically: 
POSTERIOR 
Specifically: 
TOTALS: 
No, of Pt, 
Pts. Group 
Operative 
Death? 
Diseased Vessels Not Grafted 
All Grafted LAD LCFX RCA 
2 2 
1 B YES 
1 B YES 
7 0 
+ 
+ 
5 B NO + 
1 B NO 
1 B NO 
3 2 
+ 
+ 
1 A YES + 
1 B YES + 
1 B NO + 
2 1 
1 B NO + 
_JL B YES 
14 13B 5 
1A 
+ 
1 4 1 
Abbreviations: LAD=left anterior descending; LCFX-left circumflex; 
RCA=right coronary artery; +=not grafted. 
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Major Operative Complications; Death or MI 
Data on surgical mortality and infarction were combined to determine 
if the IABP had an effect on the overall rate of major complications, 
which we defined as death or myocardial infarction in the perioperative 
period, in patients with LMCA obstruction undergoing bypass surgery. 
These results are shown in Table 19. There were 17 major complications 
in the overall group of 91 patients (18%), with 2 occurring among the 
35 Group A patients (6%), and 15 among the 56 Group B patients (27%). 
This represents a statistically significant difference between the two 
groups (p<0.05). As with incidence of operative deaths and infarctions, 
CPB time was significantly correlated with the occurrence of a major 
complication (p<0.05). Twenty-eight percent of patients with CPB times 
longer than 90 minutes suffered major complications compared to 5% of 
patients with shorter CPB times. No other statistically significant 
associations were found, but suggested correlations were the presence of 
triple vessel disease (21% vs 7%) and incomplete revascularization (27% vs 
15%). The results in each group parallel those of the overall population. 
Interdependence of the use of the IABP with specific risk factors 
was examined for the occurrence of major complications, and positive 
results are listed in Table 20. 
-62- 

Table 19. Major Operative Complications; Death or Myocardial Infarction 
Total Group A Group B 
_ (IABP) (No IABP) 
INCIDENCE 17/91 (18%) 2/35 (6%) 15/56 (27%) 
AGE 
<55 5/34 (15%) 0/10 (0%) 5/24 (21%) 
155 12/57 (21%) 2/25 (8%) 10/32 (31%) 
SEX 
M 12/73 (16%) 2/31 (6%) 10/42 (24%) 
F 5/18 (28%) 0/4 (0%) 5/14 (36%) 
PREVIOUS MI 4/37 (11%) 1/16 (6%) 3/21 (14%) 
H/0 CHF 3/24 (12%) 0/10 (0%) 3/14 (21%) 
ANGINA 
Severity: NYHA Class I 1/2 (50%) 1/2 (50%) 
Class II 4/14 (29%) 0/3 (0%) 4/11 (36%) 
Class III 4/22 (18%) 0/4 (0%) 4/18 (22%) 
Class IV 8/53 (15%) 2/28 (7%) 6/25 (24%) 
Pattern: stable 5/22 (23%) 0/6 (0%) 5/16 (31%) 
progressive 9/52 (17%) 0/16 (0%) 9/36 (25%) 
unstable 3/17 (18%) 2/13 (15%) 1/4 (25%) 
PROPRANOLOL 
none 6/14 (43%) 0/1 (0%) 6/13 (46%) 
<160mg QD 3/22 (14%) 0/6 (0%) 3/16 (19%) 
_>160mg QD 7/53 (13%) 2/28 (7%) 5/25 (20%) 
PROPRANOLOL TAPERING 
no propranolol 6/14 (43%) 0/1 (0%) 6/13 (46%) 
abrupt withdrawal 1/6 (17%) 0/1 (0%) 1/5 (20%) 
tapered or discontinued on 10/55 (18%) 2/33 (6%) 8/22 (36%) 
IABP 36 hours pre-op 
CARDIAC ENLARGEMENT 0/16 (0%) 0/6 (0%) 0/10 (0%) 
MITRAL REGURGITATION 0/6 (0%) 0/2 (0%) 0/4 (0%) 
ABNORMAL SEGMENTAL WALL MOTION 8/53 (15%) 2/25 (8%) 6/28 (21%) 
(continued) 
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Table 19. Major Operative Complications: Death or Myocardial Infarction 
(continued) 
Total Group A Group B 
_ (IABP) (No IABP) 
EF 
_> 0.60 9/39 (23%) 1/14 (7%) 8/25 (32%) 
< 0.60 4/36 (11%) 1/15 (7%) 3/21 (14%) 
LVEDP 
< 12mm Hg 7/31 (23%) 1/11 (9%) 6/20 (30%) 
> 12mm Hg 9/53 (17%) 1/23 (4%) 8/30 (27%) 
CPB TIME 
< 90 min 2/38 (5%) 0/13 (0%) 2/25 (8%) 
> 90 min 15/53 (28%) 2/22 (9%) 13/31 (42%) 
ANOXIA TIME 
0 4/27 (15%) 1/11 (9%) 3/16 (19%) 
0-30 min 5/27 (18%) 1/8 (12%) 4/19 (21%) 
31-60 min 7/30 (23%) 0/11 (0%) 7/18 (37%) 
>60 min 1/7 (14%) 0/5 (0%) 1/2 (50%) 
VESSELS DISEASED 
LMCA (RCA-NL) 1/14 (7%) 0/2 (0%) 1/12 (8%) 
LMCA+RCA 16/77 (21%) 2/33 (6%) 14/44 (32%) 
NO. OF GRAFTS PERFORMED 
1 0/1 (0%) - 0/1 (0%) 
2 6/26 (23%) 1/4 (25%) 5/22 (23%) 
3 9/56 (16%) 1/26 (4%) 8/30 (27%) 
_>4 2/7 (29%) 0/4 (0%) 2/3 (67%) 
DISEASED VESSELS NOT GRAFTED 
All grafted 9/61 (15%) 0/24 (0%) 9/37 (24%) 
One diseased vessel not 8/30 (27%) 2/11 (18%) 6/19 (31%) 
grafted 
Specifically: LAD 1/2 (50%) 0/1 (0%) 1/1 (100%) 
LCF 5/21 (24%) 1/6 (17%) 4/15 (27%) 
RCA 2/7 (29%) 1/4 (25%) 1/3 (33%) 
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Table 20. Major Operative Complications (Death on MI) 
Patients with IABP 
with Major Complications 
Patients without IABP 
with Major Complications 
P Value 
VESSELS DISEASED 
LMCA only 0/2 (0%) 1/12 (8%) NS 
LMCA+RCA 2/33 (8%) 14/44 (32%) <0.05 
CPB TIME 
<90 min 0/13 (0%) 2/25 (8%) <0.10 
>90 min 2/22 (9%) 13/31 (42%) <0.05 
AGE 
<55 0/10 (0%) 5/24 (21%) NS 
>55 2/25 (8%) 10/32 (31%) <0.10 
NS=not significant, with p value >.10 by x ^ analysis. 
An additive effect for risk of incurring a major operative complication 
was seen in patients with triple vessel disease not counterpulsated (32%) 
compared to patients with only LMCA obstruction on preoperative counter¬ 
pulsation (0%). Similarly, patients with prolonged CPB times not on pre¬ 
operative counterpulsation had a significantly higher incidence of major 
complication than patients with shorter CPB times receiving the IABP 
(42% vs 0%). The data also suggested an additive relationship to major 
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complications for age oyer 55 and not using the balloon. Thirty-one 
percent of patients oyer 55 who were not counterpulsated sustained a 
major complication at surgery compared to 0% of patients under 55 who 
were counterpulsated. No other combinations demonstrated or suggested 
additive risk properties. 
Side Effects of IABP Placement or Attempted Placement 
In addition to the 35 successful preoperative insertions of the 
IABP there were 4 unsuccessful attempts and 9 successful intra-or post¬ 
operative placements. In 3 of the unsuccessful approaches the IABP 
could not be advanced beyond the bifurcation of the abdominal aorta 
and was withdrawn without detectable complication. The fourth led to 
an aortic dissection that was recognized immediately, and the balloon- 
catheter withdrawn. No complications or further corrective procedure 
was necessary in this patient. No cases of arterial insufficiency were 
noted, and there were 2 post-operative groin infections. The overall 
complication rate was 6%, 3/48 (Table 21),and in the terminology of 
McEnamy et al (37), there were no "major" complications reported. 
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Table 21, Complications of IABP Placement or Attempted Placement 
IABP INSERTION: 
Pre-op 35 
Intra-or Post-op 9 
Unsucessful Attempts 4 
Group A 
Group B 
COMPLICATIONS 
Arterial insufficiency 0/48 (0%) 
Aortic dissection 1/48 (2%) 
Infection (groin) 2/48 (4%) 
TOTAL 3/48 (6%) 
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DISCUSSION 
Discussion of Patients and Methods 
This study reports on 91 consecutive patients with >_ 50% obstruction 
of the left main coronary artery undergoing bypass surgery at Yale-New 
Haven Hospital from June 1975 through December 1977. The frequency of 
baseline parameters for our group was consistent with that of other 
reports of patients going to bypass surgery with LMCA stenosis (14,16,18, 
20,22,25,27-29,31,32). 
Thirty-five patients in whom intraaortic balloon counterpulsation 
was instituted prior to surgery comprised Group A, and 56 patients who 
did not receive the IABP preoperatively comprised Group B. We recognize 
that biasing occurred in our groupings as a result of the clinical 
decision by the surgeon or cardiologist to insert a balloon. While in 
many cases the finding of a LMCA lesion alone was judged sufficient cri¬ 
terion for preoperative counterpulsation, maximal effort was indeed made 
to assist those patients with more severe clinical angina. A detailed 
analysis of demographic, clinical, hemodynamic, and operative descriptors 
was made to delineate the specifics of possible biasing. A significant 
difference between the groups was found only for the severity and pattern 
of anginal pain with a greater proportion of Group A patients having 
NHYA Class IV symptoms (80% vs 45%) and unstable angina (37% vs 7%). All 
other parameters were found in parallel distribution in the two groups. 
Diagnostic cardiac catheterization and calculations of hemodynamic 
parameters were performed by standard techniques. While surgical skill 
and specific technical details are surgeon-dependent, insertion of the 
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IABP and bypass grafting in this study were performed using standard 
procedures, with the exception of the method of myocardial preservation 
employed during completion of distal anastomoses of grafts. This phase 
of the procedure requires,ideally, a still and relaxed heart for a short 
period of time. In this series, performed from July 1975 through Decem¬ 
ber 1977, surgical teams used perfusion hypothermia at 28°C to 30°C with 
the heart in ventricular fibrillation. Numerous methods of cardiac 
arrest (cardioplegia) in diastole have been employed in experimental and 
clinical work at various levels of preservation of coronary perfusion. 
These include profound hypothermia, ischemic-arrest, potassium-induced 
arrest, procaine arrest, Verapamil induced arrest, and combinations of 
these (119-125). 
Extensive and detailed investigations have attempted to characterize 
metabolic, ultra-structural, and functional results using various methods 
of cardioplegia.While questions still remain regarding the superiority of 
one agent of arrest over another, as well as specific variables within 
each method, certain conclusions appear consistent in the literature. 
Infusions of various aqueous solutions into the coronary tree just prior 
to the onset of ischemia are "trapped" in the coronary vasculature for the 
duration of the ischemic period (120,124). Effectiveness of protection 
during ischemia, then, can be resolved into two distinct components: 
rapidity of induction of cardiac arrest and ability of a particular agent 
or solution to combat the deleterious changes that occur with tissue ische¬ 
mia (119,120,122-126). Although the onset of myocardial ischemia is 
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accompanied by an immediate reduction in contractile activity, this is 
not complete, and considerable contraction also occurs periodically 
during ischemia (124), Cardioplegic agents that produce instantaneous 
cardiac arrest, and thereby conserve cellular energy supplies thus, 
have a major protective effect. On a cellular level, decreasing the ex¬ 
tent of myocardial injury is dependent upon the preservation of cellular 
stores of adenosine triphosphate (ATP) and creatine phosphate (CP), and upon 
the maintanence of intracellular ion concentrations in order to preserve 
the functional integrity of myocardial cells (119,120,122,125). 
Topical hypothermia, the method used in this study, protects the 
myocardium through its ability to reduce metabolic rate, energy consumption, 
“3.t XVG 
and rate of degrad >, processes (124,126). Several investigators have 
found, however, that the addition of procaine or potassium to topical 
hypothermic solutions can increase functional recovery of the heart at 
extended ischemic times (120,126,127). This is most likely the result of 
more rapid induction of arrest and protection of intracellular ion losses 
during ischemia. Other workers have investigated the effect of combina¬ 
tions of cardioplegic agents on myocardial tolerance to ischemic arrest. 
Hearse and colleagues (124) through experiments with the working rat 
heart formulated a solution containing potassium, procaine ,ATP, and CP, 
that minimized myocardial cellular damage for prolonged periods of ischemia. 
Robb-Nicholson and associates (125), alternatively, reported on the effects 
of the calciumnt^°n:*'St: Verapi^mff°xn^2t heart model as a cardioplegic 
A A 
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and protective agent. By blocking calcium ion flux across the sarcolemmal 
membrame, Verapimil can decrease myocardial oxygen consumption and exert 
a negative inotropic effect (128,129,130). Comparing to potassium-induced 
arrest, they reported that the metabolic and physiologic effects of era- 
pamil lasted 20 minutes longer than potassium during ischemia, all other 
parameters being equal. 
It is not possible to formulate a conclusion regarding optimal 
methodology of cardiac protection during ischemic aspects of the bypass 
procedure, as research in this area is still extremely active. We note 
in regard to our series of patients that the method of myocardial preserva¬ 
tion employed during ischemia at the time of their surgery was probably 
not optimal by current standards, and may bear some consequences on the 
results obtained. This method, however, was consistent with that employed 
by most workers at that time. 
Discussion of Results 
The overall operative mortality in our series was 9% (8/91). This 
was slightly higher than, but comparable to the average results of com¬ 
bined studied listed in Table 7A of 6.6% (14,16,17,22,25,28-32,35) for 
bypass surgery performed since 1970 for LMCA stenosis. Of note in our 
results was the high correlationof intra-operative myocardial infarction 
to death. Five of the 8 operative deaths had suffered intra-operative 
infarctions (63%). 
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Of previously reported risk factors for operative mortality in coro¬ 
nary bypass procedures we found statistically significant correlations 
in this series of LMCA patients only to incomplete revascularization and 
prolonged CPB time. Abnormal left ventricular angiogram, abnormal ejection 
fraction, elevated LVEDP, mitral insufficiency, previous myocardial in¬ 
farction, history of congestive heart failure, age, severity of angina 
and the number of grafts performed demonstrated no association with in¬ 
creased mortality. The presence of triple vessel disease, however, was 
a suggested correlate, with 10% of patients with additional disease of 
the RCA succumbing at surgery compared to 0% of patients with LMCA lesions 
only. As noted, significant correlations to increased operative mortality 
were seen for two operative parameters: prolonged CPB time and incomplete 
revascularization. Other investigators have reported similar findings 
(34,58,72,77,131,132), Wiles and associates (34) and Ruel et al (131) 
found a significant increase in operative mortality among CAD patients 
with triple vessel disease. Oldham (58), EffLer (72) and their colleagues 
and Manley and Johnson (77), however, found no important difference in 
operative mortality related to the number of vessles involved. Our data 
were in between, suggesting a possible influence of lesser importance 
of 3 vessel involvement on operative mortality. Moreover, our finding 
that incomplete revascularization was significantly associated with in¬ 
creased operative risk has been noted by other workers as well. Oldham 
and colleagues (58) found an 8% operative mortality in 140 patients in 
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whom the number of bypass grafts equaled the number of vessels involved, 
compared with 14% mortality among 128 patients in whom the number of 
grafts was less than the number of vessels involved (p<0.05). Manley 
and Johnson (77) and Hammond and Poirier (132) found similar results. 
No studies have specifically looked at the correlation of CPB time 
and operative mortality (though this association has been made for in¬ 
currence of perioperative Ml-vide infra) . Prolonged CPB time can re¬ 
sult from difficult anastomoses in severely atherosclerotic coronaries, 
surgical method and experience, or a combination of these. Increased 
operative mortality associated with prolonged bypass times may be the 
result of these factors or other considerations such as hemodynamic, 
metabolic, or cellular changes that may occur during bypass. We note 
the association of prolonged CPB and increased mortality and suggest 
that, when possible, minimalization of the time on cardiopulmonary 
bypass may positively influence results for operative mortality. 
Comparison of the incidence of operative death between the group 
receiving counterpulsation prior to surgery (Group A) and the group not 
counterpulsated yielded a non-significant, but suggestive, improvement 
in operative mortality among assisted patients (11% vs 6%). We are 
cognizant that, in this comparison, the biasing in the IABP group toward 
a greater proportion of patients with more severe clinical angina may 
have influenced the results. We can speculate that if severity of 
symptoms is indeed an operative risk, as previously reported (71), a 
greater disparity in results might have been found between the groups. 
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The data in this series, however, do not substantiate such a claim. 
Cooper and associates (44) reported improvement in operative mortality 
rate among patients with left main lesions routinely assisted with counter¬ 
pulsation before bypass surgery. While their numbers were small (26 
patients) and no comparative grouping analyzed, their results were also 
suggestive of a benefit of the IABP in patients with LMCA obstruction 
going to bypass surgery. Garcia and colleagues (30) reported on the use 
of preoperative balloon counterpulsation for bypass grafting in 13 
patients with LMCA disease and compared results to 5 patients with a 
similar risk profile not receiving balloon assist. Three of their 5 
patients (60%) not counterpulsated had hypotensive episodes and cardiac 
arrest prior to the institution of cardiopulmonary bypass, of whom 2 
died (40% mortality). All of their assisted patients had uneventful 
operations and were "long-term" survivors (2 month follow-up), 0% 
mortality. Their results were statistically significant (p<0.05), 
though numbers were small. 
Transmural perioperative myocardial infarction was detected by Q 
wave ECG criteria in 15% of our overall sample. This was higher than 
results reported by other workers since 1970, which ranged from 6.9 to 
12.3%, with a mean of 8.0% (16,17,22). Several factors may play a role 
in this finding of^higher rate of perioperative MI. As noted above, 
results depend largely upon the diligence of search for MI following 
surgery. Studies designed specifically to look for perioperative in¬ 
farction in bypass surgery report a 10.7 to 30% (average=20.4%) incidence 
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(82,84,85,88,89,133-135) compared to 3.9 to 17% (average=8.4%) reported 
by workers concentrating on operative mortality (59,66,68,75,81,136,138). 
Furthermore, varying degrees of patient selection and heterogeneity of 
population groups makes comparison among results from various centers 
difficult. Finally, differing experience of surgical teams, variation 
in technique, and in particular, different methods of myocardial preserva¬ 
tion employed during ischemic phases of the operation can influence results. 
There was no correlation in our series of perioperative infarction 
to preoperative clinical presentation, hemodynamic factors such as ele¬ 
vated LVEDP and abnormal ejection fraction, abnormalities of contraction, 
nor to incomplete revascularization or time of aortic cross-clamping. A 
significant association to perioperative MI was found in patients with 
prolonged CPB times and suggested for the presence of triple vessel 
disease and for more than 3 grafts performed. Several investigators have 
noted similar results for prolonged bypass time, triple vessel disease, 
and the number of grafts performed (34,35,138). 
Our findings differed from those of Brewer et al (138), but con¬ 
curred with others (34,35) in that severity and pattern of anginal pain 
was not related to the frequency of perioperative MI in the overall 
group. We also found no association of infarction with incomplete re¬ 
vascularization, in contrast to the results of others (134,138). We 
did find, however, a correlation between the location of detected in¬ 
farcts and specific obstructed vessels not receiving a graft. 
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The mortality of perioperative myocardial infarction was 36 percent 
in this series, while patients not sustaining infarction at surgery had 
a mortality of 3.9%. This high rate demonstrates the malignant nature 
of perioperative infarction among patients with left main disease and is 
in concurrence with recent reports (34,35,61,139). 
While Group A (IABP) had a greater proportion of patients with more 
severe clinical angina, this group had a significantly lower incidence 
of perioperative MI than the unassisted group (3% vs 23%, p<0.05). Few 
studies have specifically addressed the effect of counterpulsation on 
infarction during bypass surgery for LMCA disease.Feola and colleagues 
(42), however, reported a reduction in incidence of perioperative MI 
using the IABP on CAD patients with poor left ventricular function. 
They found a 30.4% rate of infarction in the unassisted group and only 
4% in the assisted group. Garcia and associates (30) had no perioperative 
infarctions among their 13 patients with LMCA stenosis receiving pre- 
perative counterpulsation. While their unassisted cohort of 5 patients 
did poorly at surgery (2 deaths), the authors did not report on evidence 
of MI in that group. Cooper (44) and Gunstensen (140) and colleagues who 
used the IABP in small series of LMCA patients did not report on the in¬ 
cidence of perioperative MI incurred. 
An additive effect for increased risk of perioperative MI was demon¬ 
strated in patients with triple vessel disease not assisted with the 
balloon. A similar additive property was shown for prolonged CPB time 
and non-assistance with the IABP. 
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Results of perioperative infarction and operative death were 
combined to determine the overall risk of major complications. Eighteen 
percent of the 91 patients in the overall group sustained a major compli¬ 
cation, with an incidence in the assisted group of 6% and in the unassisted 
group of 27%. This difference was statistically significant and suggests 
a balloon-mediated benefit for patients with LMCA disease going to bypass 
surgery. As in the case of operative death, the overall group and each 
subgroup had an association to major complication for prolonged CPB time 
and a suggested correlation for the presence of triple vessel disease and 
incomplete revascularization. Major complications were particularly pre¬ 
valent among unassisted patients with triple vessel disease and among un¬ 
assisted patients with prolonged bypass times. The data also suggested 
an additive risk for not counterpulsating patients over the age of 55 for 
the incurrence of a major complication at bypass surgery. 
Our series of 48 attempts at IABP placement yielded a complication 
rate of only 6%, with no "major" complications, as defined by McEnamy et 
at (37). This is a significantly lower incidence than that reported by 
most workers, who in combined studies of 1128 balloon placements averaged 
18.2% overall complication rate, with 7.3% incidence of "major" complica¬ 
tion (37,97,104,105). 
Discussion of the IABP 
Intra-aortic balloon counterpulsation aids the ischemic myocardium 
by enriching the supply of oxygen through augmentation of coronary blood 
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flow and by reducing work requirements of the heart. The resulting 
improvement in balance between myocardial oxygen supply and demand can 
be of critical importance in situations of acute myocardial ischemia and 
left ventricular failure. 
Several phases of coronary bypass operations may be associated 
with significant changes in oxygen supply to the myocardium . Induction 
of anesthesia is perhaps the most critical facet of the procedure in 
patients with severely compromised coronary blood flow (23,28,24,44,47, 
141). Fluctuations in blood pressure during induction and in the period 
before institution of cardiopulmonary bypass can result in critical 
reductions in the myocardial oxygen supply/demand ratio. Cohen et al 
(47) reported in their series of 17 LMCA patients one anesthetic death 
due to refractory hypotension and ventricular fibrillation during in¬ 
duction. Zeft et al (28) noted the frequent occurrance of hypotension 
and serious arrthythmias in patients with left main obstruction during 
anesthetic induction, and recommended institution of full cardiopulmonary 
bypass as quickly as possible after anesthesia is achieved. Garcia (23), 
Cooper (44), and Urschel (141) an^co 1 leagues similarly recognized a marked 
lability in blood pressure,in patients with left main obstruction during 
anesthetic induction and operation prior to cardiopulmonary bypass. 
On a theoretical level, then, the intra-aortic balloon represents 
an effective support modality for patients with left main lesions during 
the early delicate phases of bypass surgical procedures. On a clinical 
level, our results substantiate its beneficial effect for bypass surgery 
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in this group of patients. Opinions differ at this point regarding the 
routine use of counterpulsation for surgical patients with LMCA obstruction. 
Cooper et al (44) were impressed with their results of 0% mortality among 
26 LMCA patients routinely assisted prior to surgery, and implied they 
would continue the usage of the IABP in all patients with LMCA disease. 
Garcia and associated (30), who also had good results with counterpulsa¬ 
tion, currently recommend elective preoperative balloon support in "highly 
unstable patients with coronary artery disease considered to be poor 
surgical risks". The meaning of this criterion is unclear, particularly 
in light of the fact that clinical severity of symptoms has not been 
strongly associated with operative mortality or infarction. Feola and 
colleagues (42) suggest peroperative counterpulsation for patients with 
poor left ventricular function as an adjunct for reducing surgical 
mortality. McEnamy and co-workers, in recognizing a high rate of compli¬ 
cations resulting from balloon placement in most centers, advocate 
weighing the risk against potential benefit in individual patients, 
specifically not subscribing to routine counterpulsation for left main 
patients. 
Complications resulting from balloon placements occurred in a 
relatively low incidence (6.6%, all "minor") in our series. While 
possible side effects of therapy must alwa be weighed against potential 
benefits, our data are highly suggestive of improved surgical results 
with preoperative institution of intra-aortic counterpulsation for patients 
with significant left main coronary obstruction. In the setting of 
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additional disease of the right coronary artery, or if prolonged cardio¬ 
pulmonary bypass time is anticipated, it is even more likely that pre¬ 
operative assistance with the IABP can reduce the risk of perioperative 
death or myocardial infarction. 
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